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This thesis describes the development of enantioselective synthetic methods 
promoted by primary amine-based organic catalysts. 
Chapter 1 provides a brief historic overview of asymmetric organocatalysis, 
especially on the development of asymmetric aminocatalysis via iminium or enamine 
activation.  Moreover, some selected examples of secondary and primary amine catalysts 
in this field were also illustrated in detailed. 
Chapter 2 introduces a novel primary amine-based organocatalyst, the combination 
of 9-amino(9-deoxy)epi-cinchonine and (+)-CSA, for effective conjugated addition via 
iminium ion activation of nitroesters to -unsaturated ketones.  Such a catalytic system 
could catalyze the conjugate addition in a highly enantioselective manner, affording the 
desired adducts in high yields and with up to 99% ee.  The Michael adducts are rich in 
functionality and ready to be converted into useful chiral building blocks. 
Chapter 3 presents that a mixture of 9-amino (9-deoxy) epi-quinine and ()-CSA was 
found to be the best catalyst with matching chirality, enabling the direct amination of -
branched aldehydes to proceed in quantitative yields and with nearly perfect 
enantioselectivities.  A 0.5 mol % catalyst loading was sufficient to catalyze the reaction, 
and a gram scale enantioselective synthesis of biologically important -methyl 
phenylglycine has been successfully demonstrated. 
X 
 
Chapter 4 focuses on the effective aldol reaction of acetone and hydroxyacetone to 
-unsaturated -keto ester catalyzed by the combination of 9-amino(9-deoxy)epi-
cinchonine and trifluoroacetic acid.  The desired adducts containing a chiral tertiary 
alcohol skeleton could be obtained in high yields and up to 99% ee, and an efficient 
access to 2-substituted glycerol derivatives was also demonstrated. 
XI 
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Chapter 1    Introduction 
1.1    Asymmetric Catalysis 
Nowadays, the development of enantioselective synthetic method has become one of 
the most important areas in organic chemistry.
1
  The utilizations of synthetic chiral 
molecules as enantiomerically pure pharmaceuticals, as probes of biological studies, and 
as components for materials with novel properties and functions, have made asymmetric 
catalysis a popular area of investigation.  Traditionally, transition-metal complexes and 
enzymes were regarded as two main classes of catalysts for asymmertric chemical 
reactions.
2
   
In the last century, chemists have rarely employed small organic molecules as 
catalysts, although some of the very first asymmetric catalysts were purely organic 
molecules.  Otswald introduced „organic catalyst‟ in 1900 for the first time, in order to 
differentate organic compounds as catalysts from those based on enzymes and inorganic 
compounds.
3
  In 1912, Bredig documented a modestly enantioselective cinchona alkaloid 
1 and 2-catalyzed cyanohydrins synthesis (Scheme 1.1).
4
  Only till 1969, Pracejus 
verified that organocatalyst 3 could efficiently mediate the reaction with significant 
enantioselectivities (Scheme 1.1).
5
  A milestone of asymmetric organocatalysis came in 
the 1970s.   Hajos and Wiechert reported the first and highly enantioselective catalytic 













Metal catalysts dominated the asymmetric catalysis area at the end of the last century.  
Before and during the last world war, organometallic catalysis was motivated by 
industrial research. Impressive progress in asymmetric catalysis was achieved in the 
period 1980-1990.  Sharpless and Katsuki reported a highly enantioselective epoxidation 
of allylic alcohols employing a titanium-tartrate complex as the catalyst in 1980.
8
  
Because of its generality, broad scope, high ee‟s and the predictability of configurations 
by the mnemonic rule, this method soon became a routine reaction in organic synthesis.
9-
13
  By introducing ruthenium(II)/binap 6 complex (Figure 1.1), Noyori et al developed 
practical asymmetric hydrogenation methods which have industrial applications.
14
  The 
ruthenium complex was well applied to many types of unsaturated substrates (C=C or 
C=O double bonds) in asymmetric hydrogenation.
15-18
   The asymmetric epoxidation of 
alkenes with chiral salen Mn/ 7 complexes (Figure 1.1).
19,20
 and asymmetric 
cyclopropanation of alkenes with chiral copper/ 8 (Figure 1.1) complexes,
21,22
 were also 
the typical examples.  Besides, the use of chiral Lewis acids
23-26
 became more routine.  









The transition metal-catalyzed reactions are in principle highly rational and versatile, 
although some selective transformations were devised on a rather empirical basis.  The 
catalytic activity originates from the central metal, and the possibility of stereoregulation 
is controlled by the organic ligand coordinated to the central metal.  The diverse catalytic 
activities of metallic species, coupled with the virtually unlimited permutability of the 
organic ancillaries, organometallic catalysis affords enormous possibilities and 
opportunities. However,
 
 transition metal catalysis does have drawbacks, such as high 
cost and toxicity of the metals, waste treatment resulted from uses of transition metals, 
and potential product contamination.
31
 
Enantioselective organocatalysis became a focus of research in the late 1990s and 











 and many other researchers, asymmetric organocatalytic 
methods developed fast in the last decade.  Some representative organic catalysts are 
shown in Figure 1.2.  
 




Cinchona alkaloids such as quinine 1 has been widely used as a chiral base for 
Michael addition
53,54
 or hydrophosphorylation of aldehyde.
55,56
   L-Proline 4 has been 
extensively employed as an excellent catalyst for aldol and related reactions via iminium 
or enamine activation.
39,41-43,57,58
   In recent years, cinchona alkaloids were employed  as 





  Owing to the nucleophilicity of cinchona alkaloids, they are an important motif 
for many highly enantioselective phase-transfer catalysts. Taking Corey‟s catalyst 9 as an 
example, it could mediate the alkylation of glycine imines with excellent 
enantioselectivity of up to 99.5% enantiomeric excesses (ee).
64
   
Fu et al. reported the planar chiral 4-dimethylaminopyridine (DMAP) derivative 10 
as an extremely selective catalyst for several nucleophilic catalysis.
65-67
  Since its “active 
site” is the pyridine nitrogen atom, Fu‟s catalyst 10 is also considered as an 
organocatalyst.  Jacobsen et al. introduced the chiral thiourea catalyst 11 to catalyze the 
asymmetric Strecker reaction in good yield and with excellent enantioselectivity.
36-38,68
  
Later this Schiff base catalyst was further explored in the asymmetric Mannich reaction
69
 
and hydrophosphorylation of imines.
70
  MacMillan et al. discovered that the 
phenylalanine-derived secondary amine 12 could catalyze the Diels-Alder reaction of 
α,β-unsaturated aldehydes with enantioselectivities up to 94%.45  Then numerous 
applications of catalyst 12 and related secondary amines emerged.
47,71-75
  Julia and 
Colonna et al. clarified that oligo-L-leucine 13 could be used in the asymmetric 
epoxidation of enones
76,77
 such as chalcones.
78,79
  Shi et al. synthesized the chiral ketone 






  Very recently Jorgensen et al. reported the chiral pyrrolidine derivative 15 
for the asymmetric epoxidation of aldehydes.
81
  This catalyst also worked well in a series 
of other transformations
81-83
 including domino reactions.
84-89
  Besides the above examples, 
there were many novel and efficient catalyst classes for many chemical transformations 
appearing in the last ten years.
34,90-100
  Organocatalysis, by now, has definitively matured 
to a recognized third methodology, of potentially equal status to organometallic and 
enzymatic catalysis. 
Organic molecules can catalyze chemical reactions through four different 
mechanisms
101
: (1) activation of the reaction based on the nucleophilic/electrophilic 
properties of the catalysts, the chiral catalyst is not consumed in the reaction and does not 
require parallel regeneration.  (2) organic molecules form reactive intermediates. The 
chiral catalyst is consumed in the reaction and requires regeneration in a parallel catalytic 
cycle.  (3) phase-transfer reactions, the chiral catalyst forms a host-guest complex with 
the substrate and shuttles between the standard organic solvent and a second phase.  (4) 
molecular-cavity accelerated asymmetric transformations, in which the catalyst may 
select between the competing substrates, depending on size and structure criteria.  
Organic catalysts possess notable advantages, they are typically robust, inexpensive, 
readily available, and non-toxic.  Due to their inertness to moisture and oxygen, 
demanding reaction conditions are not required in many cases. Moreover, it is very 
convenient to anchor these small organic molecules to a solid support and to reuse them, 




1.2    Asymmetric Aminocatalysis 
1.2.1 Introduction of Iminium Catalysis and Enamine Catalysis 
Many organocatalytic reactions can be regarded as amine-based reactions.
102
  In 
asymmetric aminocatalysis, chiral catalysts are often derived from amino acids, peptides, 
or alkaloids synthetic nitrogen-containing molecules.  Mostly, electrophiles are activated 


























Scheme 1.2    The iminium catalytic cycle  
Scheme 1.2 shows the iminium catalytic cycle for nucleophilic additions.  An α,β-
unsaturated aldehyde and the catalyst firstly form an iminium ion,  and then the conjugate 
addition of a nucleophile gives an enamine intermediate.  After hydrolysis, the conjugate 
addition adduct is obtained.  MacMillan et al. reported the first highly enantioselective 
Diels-Alder reactions via iminium catalysis.
45
  Later his group also utilized  the chiral 





 and conjugate additions
46








 and conjugate reductions 
utilizing the iminium catalysis were also well developed recently.
106,107
   
 
Scheme 1.3    Enamine catalysis of nucleophilic addition (left) and substitution 
reaction (right) 
Scheme 1.3 shows how enamine catalysis works.
40
  The carbonyl compound, upon 
reaction with amines, generates the enamine via iminium ion formation, and the enamine 
react with an electrophile X=Y (or X-Y) via nucleophilc addition (or substitution) to give 
an α-modified iminium ion intermediate.  After hydrolysis, the α-modified carbonyl 
product (and HY) is then obtained.  In addition to carbonyl compounds (C=O) in aldol 
reactions,
43
 enamine catalysis were also applied in other organic transformations 
involving many different electrophiles, including azodicarboxylates (N=N) in α-
aminations,
42,58
 imines (C=N) in Mannich reactions,
39
 nitrosobenzene (O=N) in α-
aminooxylation,
108
 and Michael acceptors (C=C) in conjugated additions.
109
 
In aminocatalysis, iminium catalysis and enamine catalysis are two diverging 




LUMO energy of the system, which makes them more electrophilic, acidic, and prone to 
certain pericyclic reactions.  While in enamine catalysis, carbonyl compounds are 
converted into the more nucleophilic enamines, a transformation that overall increases the 
energy of the HOMO.  Meanwhile, the iminium catalysis and enamine catalysis are 
closely related.  Iminium catalysis proceeds via enamine, while enamine catalysis 
proceeds via iminium ion formation. 
 
1.2.2 Iminium ion activation of -Unsaturated Ketones 
The stereoselective Michael addition to -unsaturated ketones is a challenging task 
in asymmetric catalysis.  Because the steric and electronic similarity of the two carbonyl 
groups does not easily permit high levels of lone-pair discrimination in the metal-
association step, it is very difficult to achieve high stereocontrol in the conjugate addition 
with metal catalysis.  The iminium ion activation can overcome the necessity of specific 
lone-pair coordination, and it can provide a suitable and general platform for completing 
highly stereoselective transformations of enones.  However, the development of an 
efficient chiral organocatalyst for ketones is still obstructed because of the problem of 
forming bulky iminium ions from ketones and the difficulty in controlling the iminium 
ion geometry.   
MacMillan et al. firstly solved this problem by designing a new imidazolidinone 
catalyst 16 for the Diels-Alder reaction with simple -unsaturated ketones (Scheme 
1.4).
71,110,111




was almost ineffective with this kind of substrate, catalyst 16 led to high 
enantioselectivity for cyclohexenyl ketones.  But the imidazolidinone 16 could not be 
widely used as a ketone activator.
110
  In this situation, Jorgensen and co-workers reported 
a chiral secondary amine catalyst 17 to the asymmetric additions of acyclic enones 
(Scheme 1.4).
112-117
  Catalyst 17 has broad applicability in conjugate addition of 
unsaturated ketones.  The reaction donors comprise sulfones,
112







Scheme 1.4    Iminium activator of simple enones and acyclic enones 
 
1.2.2.1    Chiral Primary Amines in Iminium Catalysis 
Chiral secondary amine catalysts have been demonstrated to be enormously useful 
for chemo- and enantioselective functionalization of aldehydes.
118-120




are not well applied in the asymmetric -functionalization of unsaturated ketones, usually 
resulting in sluggish reaction rates.  Therefore, a new kind of catalyst with higher 
activation ability toward enones and with the potential to approach the excellent levels of 
efficiency and generality already reached in aminocatalyzed aldehyde functionalizations 
are highly desired.  Before 2008, not much attention has been paid to the development of 
chiral primary amine catalyst.
121
  However, natural enzymes such as type  aldolases and 
decarboxylases, both containing catalytically active lysine residues, utilize a primary 
amine motif in catalysis.
122
  The chemistry community‟s low level of interest in using 
primary amines could be explained by the notion of unfavorable imine-enamine 
equilibrium.
123-125
  Yet, another reason is that the advent of proline had drawn too much 
attention to the uses of cyclic secondary amines as organic catalysts.
126,127
  With the 
advent of some recent reports demonstrating the ability of simple natural and unnatural 





 reactions via the enamine mechanism, primary amines-based catalysis has 
drawn more and more attention.  Besides the ability to complement the classical 
activation modes of proline-derived catalysts, primary amine catalysis offers the unique 
possibility of participating in processes between sterically demanding partners.
133-135
  
Therefore, it overcomes the difficulties of chiral secondary amines in generating 





Figure 1.3    Steric Factors in iminium ion activation 
 
Recently, chiral primary amine derivatives have also been tested as iminium ion 
activators for challenging classes of unsaturated carbonyl compounds.  Ascribed to their 
steric hindrance, the efficient activation of -substituted -unsaturated aldehydes by 
MacMillan imidazolidinone catalysts 12 or by diarylprolinol ether 15 is generally 
difficult.  Ishihara and Nakano revealed that the first enantioselective Diels-Alder 
reaction with -substituted acroleins was successfully realized by a novel primary amine-
based organocatalyst 18.
94,136,137
  Specially, a variety of dienes reacted with -
(acyloxy)acroleins and resulted in very good yields and high enantioselectivity (Scheme 






Scheme 1.5    Primary amines in iminium catalysis: Diels-Alder reaction of -
substituted acroleins 
 
Chin and co-workers reported the first example of using primary amines in iminium 
ion activation of acyclic unsaturated ketones in 2006.
138
  Interestingly, Chin and co-
workers started their studies by making efforts to elucidate the reaction mechanism of the 
warfarin synthesis, which was previously described by Jorgensen.  They described an 
asymmetric conjugate addition of 4-hydroxycoumarin to enone via iminium ion 
activation by the secondary amine catalyst 19 (Scheme 1.6).
73
  It was discovered that 
under the reaction conditions, imidazolidine 19 is not the real catalyst of the process 
because it decomposed to 1,2-diphenylethylene-diamine 20.  With an excess of acetic 
acid, this diamine 20 could promote the enantioselective conjugate addition of 4-





Scheme 1.6    Iminium activators of acyclic enones 
 
At the end of 2006, the utilization of chiral primary amines‟ in iminium catalysis and 
enamine catalysis started to expand rapidly, which in many cases could complement to 
the existing secondary amine-based catalytic methods.   
 
1.2.2.2    Asymmetric Counteranion-Directed Catalysis 
In 2006, List and co-workers introduced a novel strategy for enantioselective 
synthesis: asymmetric counteranion-directed catalysis (ACDC).
139-142
  Based on the fact 
that most chemical transformations proceed through charged intermediates or transition 
states, the utilization of suitable chiral catalysts, which are able to form chiral ion pairs, 
could induce high stereochemical control.  Consequently, when a chiral counteranion is 
employed as a catalyst in the catalytic reactions proceeding via cationic intermediates, the 
reactions could be performed in an enantioselective manner.  This concept was applied to 




derived from the condensation of amine catalysts and carbonyls are positively charged.  
The asymmetric biomimetic transfer hydrogenation of -unsaturated aldehydes was an 
example (Scheme 1.7).
139
  The catalytic ammonium salt 22, produced by combination of 
an achiral secondary amine such as morpholine and the chiral phosphoric acid 21 [3,3‟-
bis(2,4,6-triisopropylphenyl)-1,1‟-binaphthyl-2,2‟-diyl hydrogen phosphante (TRIP)], 
regarded as ACDC, was found to function as a highly enantioselective iminium catalyst 
in the conjugate reduction of enals.  It should be noted that using chiral binaphthol-
derived phosphoric acid derivatives as the counteranion was inspired by the high 









Accordingly, the ACDC concept was extended to the asymmetric transfer 
hydrogenation of -unsaturated ketones (Scheme 1.7).140  The new catalytic primary 
amine salt 23 was studied, in order to improve stereoselectivity.  Both the cation and 
anion of the catalytic salt 23 are chiral.  The efficient activation can be ascribed to the 
proven ability of primary amines to form congested iminium ion intermediates from 
ketones, and the power of asymmetric counteranion-directed catalysis. 
 
1.2.2.3    Cinchona Alkaloid Derived Primary Amine Salt for Iminium 
Acitivation of Enones 
Both primary amine catalysis and ACDC strategy verified their potential as novel 
and useful organocatalytic tools.  At the same time, the forefront of Bronsted base 
catalysis research was represented by the engineering and synthesis of bifunctional chiral 
catalysts, which were able to simultaneously bind and activate two reacting partners.  
Therefore, numerous efforts were dedicated to the „privileged‟ natural scaffold of 
cinchona alkaloids‟ derivatives in order to improve the dual activation ability of the 
catalysts.  The research mainly focused on introducing efficient, tunable hydrogen-
bonding donor groups and keeping the basic bridgehead nitrogen in the quinulidine 
core.
145,146
  In this context, thiourea 24 was proved to be one of the most useful and 
general bifunctional organic catalysts.
147-150
  Thiourea 24 is easily prepared by a two-step 
procedure from quinine 1 (Scheme 1.8).
149,150
  The quinine derived primary amine 




benefit of using a less hindered chiral primary amine catalyst, compound 25 was tested to 
activate enones via the iminium catalysis by Melchiorre group.
151
  When they combined 
the catalyst 25 with achiral acids, such as TFA, only moderate enantioselectivities were 
observed for asymmetric Friedel-Crafts-type alkylation.  Inspired by asymmetric 
counteranion-directed catslysis (ACDC), Melchiorre and co-workers discovered the high 
reactivity and enantioselectivity of catalyst salt derived from the combination of primary 
amine 25 with N-Boc-D-phenylglycine 26 (Scheme 1.9).  At almost the same time, Chen 
and co-workers also reported the asymmetric alkylation of indoles with simple 
unsaturated ketones catalyzed by 30 mol% TfOH salt of cinchonine derived primary 
amine.
152
   
 





Scheme 1.9    Catalyst salt promoted asymmetric alkylation of indole with simple 
enones 
Melchiorre group examined the catalyst salt of 25 and 26 in oxa-Michael addition, 
the conjugate addition of the commercially available 2,4-dimethoxybenzaldoxime to 
simple enones (Scheme 1.10).  It was found that 1:1.5 ratio of the quinine derived 
primary amine 25 to N-Boc-D-phenylglycine 26 represented the best compromise 
between the catalyst loading and catalytic efficiency.  The asymmetric oxa-Michael 
addition adducts could be transformed to optically active 1,3-diols, which are highly 
valuable chiral structural motifs present in many polyketide-derived natural products of 
proven biological activity.
153,154





Scheme 1.10    Catalyst salt promoted asymmetric -hydroxylation of -
unsaturated ketones using oxime 
Melchiorre and co-workers further applied their typical catalyst salt of 25 and 26 to 
mediate the highly chemo- and enantioselective sulfa-Michael addition to enones via 





Scheme 1.11    Catalyst salt promoted asymmetric sulfa-Michael addition of tert-




1.2.3 Direct -Amination Reactions via Enamine Mechanism 
In 2002, the first successful proline-catalyzed enantioselective direct -amination of 





 independently.  Consequently, a series of -aminations of simple and branched 
aliphatic aldehydes, aliphatic cyclic and acyclic ketones catalyzed by proline and its 
derivatives have been studied.
120,158,159





 and chichona aldaloids derivatives
164
 also worked 
well in similar reactions, which used 1,3-dicarbonyl compounds or -substituted--
cyanoacetates as substrates.   
 
1.2.3.1    Asymmetric -Amination Catalyzed by Proline, Proline Analogs and 
Other Secondary Amine Catalysts  
The first example of L-proline 4 successfully catalyzed -amination was the reaction 
between the simple -unbranched aldehydes and various azodicarboxylate esters.156  
Because of the presence of an acidic -H, the -amination adducts are unstable, which is 
the reason that they are usually reduced in situ to the corresponding aminoalcohols or 
cyclized to N-aminooxazolidiones (Scheme 1.12).
157,160,165-167
  Later, proline
168,169
 and its 
derivatives, containing pyrrolidinyl tetrazole 27
170,171
 and L-azetidine-2-carboxylic acid 
28,
168
 were employed in -amination of -branched aldehydes, generating quaternary 
stereogenic centers at the -position with from essentially none to 99% 




to accelerate the reactivity of proline-catalyzed amination.  In this method, both the yields 
and enatioselectivities were increased after shorter reaction time, and pyrrolidinyl 
terazole 27 was proved to be a more effective catalyst for amination of 2-phenylpropanal 
derivatives than L-proline 4.
171
  The corresponding -amination adducts of indane-1-
carboxaldehydes were obtained in 99% yield and >99% ee and were consequently 





Scheme 1.12    Proline and derivatives catalyzed -amination of aldehydes 
The direct -amination of ketones was also reported by Jorgensen and coworkers.  
The reaction of simple aliphatic ketones with diethyl azodicarboxylate was catalyzed by 
L-proline 4 with excellent enantioselectivities and moderate regioselectivities as the 






The reaction results of cyclic ketones such as cyclohexanone and derivatives were poor 
when catalyzed by L-proline 4.  While L-azetidine-2-carboxylic acid 28 was employed for 
cyclic ketones substrates, the enantioselectivities could be increased to 88-90%.
173
  
Besides, the benzimidazole-pyrrolidine (BIP) catalyst 29 and 4-silyloxyproline 30 were 
comparable to L-proline 4 in terms of enantioselectivity with cyclohexanone and 1-
silacyclohexan-4-one as substrates (Scheme 1.13).
174,175
  The catalyst 30 was also proved 
to be a general catalyst for amination of ketones because it could also accept acyclic 
ketones and -branched aldehydes as substrates. 
 
 




In order to optimize the reaction condition of L-proline 4 catalyzed -amination of 
aldehydes and kentos, ionic liquids have also been tested,
176
 both the reactivity and 
enantioselectivity were not as good as those obtained from reactions in conventional 
solvents. 
The sulfonamide catalyst 31 is based on the proline skeleton with a hydrogen-
bonding donating substitent (Scheme 1.14).
165
  It could activate the aldehyde via enamine 
catalysis, and activate the electrophile via hydrogen-bonding.  However, the existence of 
a hydrogen-bonding group was not prerequisite to high activities and enantioselectivities.  
A silyl-protected diarylprolinol catalyst 32 was developed by Jorgensen et al.
166
  
Although it could not participate in hydrogen-bonding, the enantioselectiveies could also 
be generated by controlling the geometry of the enamine and by steric bias of the two 
enamine faces by the bulky substituent on the pyrrolidine ring of the catalyst.  With 10 
mol% of catalyst 32, the -amination of aldehydes with diethyl azodicarboxylate or 
diisopropyl azodicarboxylate could be completed in 15 min at room temperature, giving 
the product in 73-88% yield and 90-97% ee (Scheme 1.14).   
 




An interesting aspect of catalyst 32 is that it has the same absolute configuration with 
L-proline 4, however, the -amination adducts catalyzed by 32 and 4 were opposite 
enatiomers.  The possible explain of this phenomenon was given by Blackmond et al. 
(Figure 1.4).
177
  These two different transition state models can explain the observed 
phenomenon, yet, they could not verify the autoinductive behavior and asymmetric 
amplification found by detailed kinetic analysis.
178,179
  Only in amination and 
aminoxylation, such unusual kinetics for proline-catalyzed reactions are discovered, not 
in aldol reactions.   
 
Figure 1.4    Models to explain the opposite enantioselectivity of amination of 
aldehydes catalyzed by 4 and 32 
 
In 2004, Jorgensen and co-workers reported the first organocatalytic -amination of 
-substituted -cyanoacetates, and they proved the cinchona alkaloid -isocupreidine 33 
as the effective catalyst for -amination of a series of -aryl -cyanoacetates.180  The 




aryl -cyanoacetates and -alkyl -cyanoacetates. 181,182  Besides, other chiral amines 
such as 36 and 37 have also been reported as catalysts for -amination of ethyl -phenyl 
-cyanoacetate.183  But they could not achieve as high enantioselectivities as catalysts 33-
35 (Scheme 1.15).   
 
Scheme 1.15    Direct -amination of -substituted -cyanoacetates 
 
L-Proline 4 was applied to mediate the tosyl and nosyl azides to react with -
branched aldehydes, and the reaction proceeded well to yield configurationally stable -
sulfamidated aldehydes in ee ranging from poor to 86%.  However, when using -
unbranched aldehydes as substrates, instead of desired sulfamidated products, N-
tosylamides were obtained (Scheme 1.16).
184





Scheme 1.16    -sulfonylamidation of -branched aldehydes catalyzed by L-proline 
4 
 
1.2.3.2    Asymmetric -Amination Catalyzed by Primary Amine Catalysts 
For aromatic ketones, proline and its derivatives are generally not efficient catalysts 
of -amination and other electrophilic reactions.  Recently, cinchona alkaloids derived 
primary amines were successfully used as catalysts for an enantioselective direct -
amination of aromatic ketones (Scheme 1.17).
185
  The cinchonine derived primary amine 
catalyst 38 could mediate various aromatic ketones with excellent enantioselectivities.  
When changing the catalyst to quinine derived primary amine 25, the opposite 
enantiomer of the -aminated adduct was obtained in low yield and poor enatiomeric 





Scheme 1.17    Direct -amination of aromatic ketones catalyzed by primary amines 
derived from cinchona alkaloids 
 
1.2.4 Aldol Reaction via Enamine Activation 
In modern  organic synthesis, asymmetric aldol reaction is one of the most important 
reactions,
186
 which affords synthetically highly useful β-hydroxy carbonyl compounds.187  
Ever since the discovery of the catalytic asymmetric aldol reaction by Mukaiyama et 
al.,
188
 numerous metal-catalyzed asymmetric aldol reaction have been developed.
189-193
 
Various new concepts about organic catalysts have been developed during the last few 
years.
101
  Enolates were employed as donors of indirect aldol reactions and unmodified 
ketones were employed as donors of direct aldol reactions.  Denmark et al. have showed 
that phosphoramides could work as catalysts for the asymmetric indirect aldol reaction.
34
  
Consequently, the cinchona alkaloid-based ammonium salt or carbocation was also 






1.2.4.1    Asymmetric Aldol Reactions Catalyzed by Proline and Its Analogues  
Application of L-proline in direct asymmetric aldol reaction was first reported in the 
early 1970s (Scheme 1.1).
6,7
  And the enantiomerically pure aldol adduct was an useful 
synthon for constructing a series of biologically active compounds such as steroids, 
terpeonids, and taxol.
196,197
  It was until 2000 that proline was used by List et al. in the 
intermolecular aldol reactions.
43
  Excellent yields and enantioselectivities were obtained 
when acetone was added to various aldehydes (Scheme 1.18).  List and co-workers 
examined hydroxyacetone as a donor of aldol reaction to afford anti-1,2-diols with 
excellent enantioselectivity (Scheme 1.18),
198
 which was the first catalytic asymmetric 
synthesis of anti-1,2-diols and complemented the asymmetric dihydroxylation developed 
by Sharpless and other researchers.
199
  L-Proline-catalyzed aldol reaction between simple 
cyclic ketones and aldehydes acceptors have also been reported by List and co-workers 





Scheme 1.18    Early examples of L-Proline-catalyzed aldol reactions reported by 
List 
Zhou and Shan discovered that adding only 1% of (S)-BINOL to proline-
catalyzedaldol reactions between acetone and aromatic aldehydes improved the 




Scheme 1.19    Effects of BINOL on the enantioselectivity of organocatalyzed aldol 




Hydroxyacetone is an effective donor in proline-catalyzedaldol reaction, but 
dihydroxyacetone was unreactive unless the hydroxyl groups were blocked.
202
  The anti-
adducts were formed in good yields and selectivities of ketal substructures (Scheme 1.20).   
 
Scheme 1.20    Aldol reaction of dihydroxyacetone derivatives catalyzed by L-
proline 
 
Proline was applied to the first asymmetric enolexo aldolizations.
203
  Dicarboyl 
compounds formed cyclic -hydroxy aldehydes through cyclizaiton and proceeded with 
high yield, enantioselectivities and diastereoselectivites (Scheme 1.21).  Another example 
of enolexo cyclization of ketoaldehydes mediated by proline was reported recently, in 











 L-proline has been used to catalyze the synthesis of -hydroxy--amino 
aldehydes and -hydroxy--amino aldehydes from glycyl aldehyde (Scheme 1.22).206  
The direct aldol reactions with glycine enolate donors are very limited. 
 





In order to synthesize of ulosonic acids, Enders and Gasperi applied proline as an 
effective catalyst for the addition of keto dimethylacetal to aldehydes.
207
  Although the 
reaction time was quite long, a series of -disubstituted aldehydes could be utilized as 
acceptors (Scheme 1.23). 
 
Scheme 1.23    Proline-catalyzed aldol reactions to synthesize high oxygenated 
adducts 
 
L-Proline was also reported to catalyze the addition of methyl ketones to -thio 
substituted cycloalkyl aldehydes (Scheme 1.24),
208
 excellent enantioselectivity and 
variable reactivity were observed for adducts. 
 




The excellent selectivities of proline-catalyzed reactions can be ascribed to the 
formation of highly organized transition states with extensive hydrogen-bonding 
networks (Scheme 1.25).  The proton transfer from amine or carboxylic acid group of 
proline to alkoxide or imide is essential for charge stabilization and C-C bond formation 




Scheme 1.25    The L-proline-mediated enamine catalytic cycle 
 
In addition to proline, many proline derivatives have also been developed over time.  
Proline‟s supremacy is being challenged by new synthetic analogues,215-222 and more-
complex oligopeptides.
223





Figure 1.5    Proline analogues used as organic catalysts 
 
1.2.4.2    Asymmetric Aldol Reactions catalyzed by primary amine catalysts 
In contrast to secondary amines and peptides containing a secondary amine at the N-
terminus, which have gained much attention for the aldol reactions
43,216,224-227
, primary 
amines or peptides with primary amine groups at the N-termini were regarded as poor 
catalysts for the direct intermolecular aldol reactions.
43,228





  Cordova et al. demonstrated that acyclic 
natural amino acids such as alanine, valine, isoleucine catalyzed the direct asymmetric 
aldol reactions in wet dimethylsulfoxide (DMSO) with excellent stereoselectivities, and 
furnished the corresponding β–hydroxy ketones in high yields and up to > 99% ee 
(Scheme 1.26).  Alanine peptides have also been evaluated as organic catalysts, however, 






phenylalanine showed to ben the most promising organocatalyst among a series of 
dipeptides.
233
   
 
Scheme 1.26    Aldol reactions catalyzed by L-alanine 
Aldol reaction between cyclohexanone with aromatic aldehydes were chosen to be 
model reactions for other simple amino acids as catalysts in aqueous solution (Scheme 
1.27).
234-236
  Our group and Amedjkouh both found that L-tryptophan 51could be an 
effective catalyst in water.  To further optimizing the same model reactions, Deng and 
Cai found that with 20 mol% of a surfactant, L-arginine 52 was the most generally useful 
catalyst.  Silyl-protected Serine derivative 53 proved to be an effective catalyst for the 








Besides, our group also reported that simple natural threonine derivatives showed 
better selectivities for the direct aldol reactions (Scheme 1.28).
238
  Nearly the same time, 
Barbas reported that L-threonine or O-tBu-L-threonine could catalyze the syn-selective 
aldol reaction of α-hydroxyketones in dimethyl formamide (DMF) or N-
methylpyrrolidone (NMP). 
129,239,240
  The system reported by Barbas only worked for few 
selected substrates and the primary amino acid catalysts demonstrated low efficiency (20-
30 mol% loading). 
 
Scheme 1.28    O-TBS L-threonine organocatalysis 
 
Scheme 1.29 illustrates a plausible primary amino acid-mediated enamine 
mechanism.
232
   The amino acid reacts with the ketone donor, affording an enamine, 






Scheme 1.29    Mechanism of the acyclic amino acid-catalyzed direct asymmetric 
aldol reaction 
 
Not only the primary amino acids and derivatives described above were used in the 
asymmetric aldol reactions, but also some other primary amines were regarded as organic 
catalysts in the aldol reaction recent years.
238,241-243
  Notably, cinchonine derived primary 
amine 38 was also used to catalyze the addition of cyclic ketones to aromatic aldehydes 
(Scheme 1.30).
244
  Aldehydes containing electro-withdrawing groups were the most 
successful substrates.  Some typical examples of chiral primary amine catalysts are 





Scheme 1.30    Cinchonine derived primary amine catalyzed crossed-aldol reactions 
 
 





1.3    Project Objectives 
Quaternary carbon centers widely present in natural products and pharmaceutical 
agents; hence, their efficient asymmetric synthesis has been intensively investigated in 
the past few decades.  The following are the objectives of this thesis work. 
1.    Development of asymmetric conjugated addition of nitroesters to α,β-
unsaturated ketones via iminium catalysis.   
2.    Given the importance of α-alkylated phenylglycine and its derivatives, we intend 
to develop an effective organocatalytic amination protocol for the branched aldehydes.   
3.    The intermolecular aldol reactions of the ketone-aldehyde type and aldehyde-
aldehyde type are common.  In contrast, catalytic asymmetric intermolecular aldol 
reactions of the ketone-ketone type are less explored, and we set out to develop efficient 
process in this direction. 
The purpose of this study is to design and synthesize different primary amine 
catalysts which can mediate highly enantioselective reactions, with the particular focuses 
on the above described reactions, and our specific amins are: 
1.    Develop an efficient asymmetric aminocatalytic conjugated addition of 
nitroesters to α,β-unsaturated enones and a convinient protocol that allows rapid access to 





2.    Devise a general approach for the organocatalytic amination of branched 
aldehydes promoted by chiral primary amines, and prepare unnatural amino acids in a 
practical manner. 
3.    Apply the cinchona-based primary amine catalysts in the asymmetric 
intermolecular aldol reactions, and the products are tertiary alcohols which could be 
converted into other various function groups. 
The details of our studies toward these objectives are described in the following 







Chapter 2    Primary Amine/(+)-CSA Salt-Promoted 
Organocatalytic Conjugate Addition of Nitroesters to Enones 
 
2.1    Nitroesters in Organocatalytic Conjugate Addition 
The conjugate addition of the stabilized carbanions to α,β-unsaturated carbonyl 
compounds represents one fundamental carbon carbon bond-forming reaction in organic 
synthesis, and the development of chiral catalysts for the asymmetric version of this 
reaction constitutes an important research field and has been well-explored in recent 
years.
245,246
  In particular, small organic molecules have been found to be extremely 
useful in promoting asymmetric conjugate addition reactions.
247,248
  Since MacMillan‟s 
introduction of iminium catalysis as a general mode of activation in asymmetric 
catalysis,
249
 this LUMO-lowering strategy has been firmly established and has found 
wide applications in asymmetric synthesis.
250-253
  It should be noted that catalysts used for 
the iminium ion activations in the early days are mostly chiral secondary amines, and 
have been utilized mainly for the activation of -unsaturated aldehydes.  Primary 
amine-based organocatalytic synthetic methods have emerged as powerful and versatile 
tools in asymmetric synthesis recently.
121,164,254-256
  In particular, chiral primary amines 
are extremely useful in iminium catalysis, and reactions catalyzed by primary amines in 
many cases are better or complementary to those achieved with reactions promoted by 
pyrrolidine-based secondary amine catalysts. 
136,138,140,151,152,155,257-263
  As part of our 






 we became interested in the design of novel organocatalytic 
reactions utilizing primary amine-induced iminium ion activation. 
Nitroesters are valuable sources of stabilized carbanions in organic synthesis, and 
they have been used as masked amino acids in various organic transformations.
271-273
   
However, enantioselective reactions employing nitroesters are currently very limited.
274-
276
  In this context, we were intrigued to develop an organocatalytic asymmetric addition 
of nitroesters to α,β-unsaturated ketones, as examples of this type of enantioselective 
conjugate additions are scarce in the literature.  Ikariya and co-workers reported 
enantioselective addition of ethyl nitroacetate to cyclopentenone, catalyzed by a chiral 
ruthenium complex.
277
  Jørgensen et al. prepared a number of novel secondary amine 
organic catalysts, and applied them in the Michael addition of nitroacetate to α,β-
unsaturated ketones.  The products were formed with good enantioselectivities, and no 
diastereroselectivity was observed.
115,278
  Although very interesting, those reported 
reactions suffered from very low reaction rates, and virtually no reaction scope was 
explored in these studies.  We envisaged that an enantioselective conjugate addition of 
nitroesters to enones maybe be achieved via efficient iminium ion activation of enones by 
primary amine-based organic catalysts.  Herein, we show that the combination of (+)-
camphorsulfonic acid (CSA) with cinchonidine results in an effective organic catalyst, 
which catalyzed the enantioselective conjugate addition of nitroacetate to α,β-unsaturated 





2.2    Results and Discussion 
2.2.1    Catalyst and Solvent Screening 
The reaction between ethyl nitroacetate 2-1a and trans-4-phenyl-3-buten-2-one 2-2a 
was chosen as a model reaction, and the catalytic effects of various primary amine 
catalysts were examined, and the results are summarized in Table 2.1.  (1S,2S)-1,2-
Diphenylethane-1,2-diamine-derived primary amine catalysts containing thiourea (59), 
and sulfonamides (60 and 61), in combination with p-nitrobenzoic acid, were found to be 
effective, affording the desired products in excellent yields and with moderate to good 
enantioselectivities (entries 1 to 3).  O-TBS-L-Threonine 54 gave almost racemic 
products (entry 4).  Cinchona alkaloids are privileged chrial structural scaffolds in 
asymmetric catalysis,
279
 various cinchona alkaloids were next investigated.  9-amino(9-
deoxy)epi-cinchonine (38), combining with p-nitrobenzoic acid or p-toluenesulfonic acid, 
afforded the products in low yields (entries 5 and 6).  We reasoned the nature of the 
counteranion might be important in the  asymmetric induction,
139,140
 we thus decided to 
introduce chiral acid to the catalytic system, and camphorsulfonic acid (CSA) was 
selected.  While (-)-CSA salt of 8 gave very good results, (+)-CSA salt of 38 turned out 
to be a even better catalyst, affording the desired adducts in excellent yield and with 99% 
ee, although litte diastereoselectivity was observed (entry 8).  Primary amines derived 
from cinchonidine (61) and quinine (25) were less effective (entries 9 and 10), quinidine  
(62) or 6‟-demethylated quinidine (63)-based primary amine was equally effective 




catalyst for the further reactions since such system gave marginally higher yield of the 
product.     
























1 59 pNO2PhCO2H 24 74 1:1 77/80 
2 60 pNO2PhCO2H 9 91 1:1 66/65 
3 61 pNO2PhCO2H 48 97 1:1 83/83 




5 38 pNO2PhCO2H 24 39 1:1 98/98 
6 38 TsOH 24 59 1:1 91/90 
7 38 (-)-CSA 24 89 1:1 94/93 
8 38 (+)-CSA 24 94 1:1 99/99 
9 61 (+)-CSA
e
 24 80 1:1 -77/- 86
f 
10 25 (+)-CSA 24 80 1:1 -77/ -84 
11 62 (+)-CSA 24  89 1:1 99/99 
12 63 (+)-CSA 20 87 1:1 97/86 
 
a
 Reactions were performed with 4-phenyl-but-3-en-2-one (0.1 mmol), ethyl nitroacetate (0.2 





 Determined by 
1
H NMR analysis of the products.  
d
 The ee value was determined by 
chiral HPLC analysis.  
e
 20 mol % additive.  
f
 „+‟ ee value and „-‟ ee value mean two 
enatioisomers. 
 
2.2.2    Reaction Scope 




The influence of ester moieties of different nitroesters on the reactions were next 
examined (Scheme 2.1).  tert-Butyl nitroacetate offered slightly improved 
diastereoselectivity, however, the chemical yield dropped significantly.  Benzyl 
nitroacetate turned out to be completely ineffective, affording the adducts in nearly 
racemic form.   In contrast to unbranched nitroesters, -substitued ethyl nitroacetate was 
unsuitable for the conjugate addition reaction, and no desired product was obtained.  We 
previously employed fluorinated nucleophiles
280-285
 for the asymmetric generation of 
fluorinated quaternary chiral centers, when -fluorinated nitroacetate was employed, the 
conjugate addition also could not proceed. 
 









2.2.2.2    α,β-Unsaturated Ketones Screening 
To establish the reaction scope, a number of enones were employed as acceptors, and 
the results are summarized in Table 2.2.  Reactions are applicable to various -aryl-
substituted butenones, and conjugate addition products were obtained with very high 
enantioselectivity, however, virtually no diastereoselectivities were observed (entries 1 to 
7).  Cyclic enones, such as cyclohexenone and cyclohaptenone, were also excellent 
acceptors for the conjugation additions, affording the desired products in high yields and 
with excellent enantioselectivity (entries 8 and 9). 
 
































































































 Reactions were performed with enone (0.1 mmol), ethyl nitroacetate (0.2 mmol), 38 (0.01 
mmol), (+)-CSA (0.01 mmol) in para-xylene (0.1 mL) at room temperature. 
b





H NMR analysis of the products 
d
 The ee value was determined by chiral HPLC 
analysis.  
2.3    Synthetic Manipulations of Michael Adducts 
The Michael adducts obtained from the catalytic enantioselective conjugate addition 
of ethyl nitroacetate to α,β-unsaturated ketones are rich in functionality, and ready to be 
converted into useful chiral building blocks (Scheme 2.2).  The facile reduction of the 
nitro group, followed by in situ reductive amination afforded chiral pyrrolidine 2-4 as a 
single stereoisomer.
115
  To partially circumvent the low diastereoselectivities of our 
reactions, adduct 2-3a was subjected to electrophilic fluorination reaction to yield 2-5 
with fluorinated quaternary centers.  The two diastereomers of 2-5 can be easily separated 
by column chromatographic purification, which can be further converted to optically pure 
-fluorinated ester 2-6 or -fluorinated nitro compound 2-7 following the procedures 
reported in the literature.
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2.4    Conclusion 
In summary, we discovered that combination of 9-amino(9-deoxy)epi-cinchonine 38 
and (+)-CSA resulted in a novel primary amine-based catalyst for efficient activation of 
α,β-unsaturated ketones via iminium intermediates.  The CSA salt of 38 was capable of 
catalyzing the conjugate addition of nitro acetate to enones in a highly enantioselective 
manner, affording the desired adducts in excellent yields and with up to 99% ee.  
Extension of this useful iminium catalyst to other catalytic asymmetric reactions, 
particularly those involving enone substrates are under investigation in our laboratory. 
 
2.5    Experimental Section 









C NMR spectra were recorded on a Bruker ACF300 or a DPX300 
(300 MHz) or an AMX500 (500 MHz) spectrometer.  Chemical shifts were reported in 
parts per million (ppm), and the residual solvent peak was used as an internal reference: 
proton (chloroform δ 7.26), carbon (chloroform δ 77.0).  Multiplicity was indicated as 
follows: s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), dd (doublet of 
doublet), br s (broad singlet).  Coupling constants were reported in Hertz (Hz).  Low 
resolution mass spectra were obtained on a Finnigan/MAT LCQ spectrometer in ESI 
mode, and a Finnigan/MAT 95XL-T mass spectrometer in FAB mode.  All high 
resolution mass spectra were obtained on a Finnigan/MAT 95XL-T spectrometer.  For 
thin-layer chromatography (TLC), Merck pre-coated TLC plates (Merck 60 F254) were 
used, and compounds were visualized under a UV light at 254 nm.  Further visualization 
was achieved by staining with iodine, or ceric ammonium molybdate followed by heating 
on a hot plate.  Flash chromatographic separations were performed on Merck 60 (0.040 - 
0.063 mm) mesh silica gel.  The enantiomeric excesses of products were determined by 
chiral-phase HPLC analysis.  The hydrogenation was performed by using H-Cube
TM
.   
Ethyl nitroacetate, trans-4-phenyl-3-buten-2-one, cyclohexenone and 
cyclohaptenone were purchased from Sigma-Aldrich and used as received.   Other 
nitroesters
287






2.5.2    Representative Procedure 
 
 
Ethyl nitroacetate (22 μl, 0.2 mmol) was added to a mixture of 9-amino(9-deoxy)epi-
cinchonine 38 (2.9 mg, 0.01 mmol),  (+)-CSA (4.6 mg, 0.02 mmol) and trans-4-phenyl-
3-buten-2-one (14.6 mg, 0.1 mmol) in para-xylene (0.2 mL) in a sample vial at room 
temperature.  The vial was then sealed and the reaction mixture was stirred at room 
temperature for 24 hours.  Then the solvent was concentrated in vacuo and the residue 
was purified by flash column chromatography (ethyl acetate/hexanes = 1:10 to 1:3) to 
afford the desired product as a white solid (26.2 mg, 94%).  
 
2.5.3    Determination of Absolute Configurations of the Michael Adducts 
 
 
Following the representative procedure illustrated in section B, the Michael addition 




3a, which was decarboxylated to yield the known compound A, the configuration of 
which was determined by comparison with the literature data.
290
  The configurations of 
other Michael adducts were assigned by analogy. 
 
(R)-5-Nitro-4-phenylpentan-2-one A 
To a solution of (3R)-ethyl 2-nitro-5-oxo-3-phenylhexanoate 2-3a (83.7 mg, 0.3 
mmol) in ethanol (3 mL) was added 2 M NaOH aqueous solution (2.5 mL, 5 mmol).  The 
suspension was allowed to stir at room temperature overnight.  Then the reaction mixture 
was concentrated and the residue was taken up in ethyl acetate (10 mL).  The organic 
extracts were washed with 1N HCl (3 X 5 mL), saturated NaHCO3 (3 X 5 mL) and brine, 
respectively, and dried over Na2SO4.  After filtration, the filtrate was concentrated and 
purified by flash column chromatography (ethyl acetate/hexanes = 1:3) to afford the 
desired product as a colorless oil (54.1 mg, 87%).  The analytic data of the compound A 





Following the representative procedure illustrated in section B, the Michael addition 
of ethyl nitroacetate to cyclohexenone was performed to give the adduct 2-3l, which was 




determined by comparison with the literature data.
116
  The configurations of other 
Michael adducts using cyclic enones were assigned by analogy. 
 
(R)-3-(Nitromethyl)cyclohexanone B 
To a solution of ethyl 2-nitro-2-((R)-3-oxocyclohexyl)acetate 2-3l (68.7 mg, 0.3 
mmol) in ethanol (0.6 mL) was added 1M LiOH aqueous solution (0.6 mL, 0.6 mmol). 
The suspension was allowed to stir at room temperature overnight. Then the reaction 
mixture was concentrated and the residue was taken up in ethyl acetate (5 mL). The 
organic extracts were washed with 1N HCl (3 X 2 mL), sat. NaHCO3 (3 X 2 mL) and 
brine respectively, and dried over Na2SO4. After filtration, the filtrate was concentrated 
and purified by flash column chromatography (ethyl acetate/hexanes = 1:3) to afford the 
desired product as a colorless oil (34.5 mg, 73%). The analytic data of the compound B 










Following the representative procedure illustrated in section B, the Michael addition 
of ethyl nitroacetate to trans-4-phenyl-3-buten-2-one was performed to give the adduct 3a, 
which was subjected to reductive amination by using H-Cube
TM
 to yield the (2R,3R,5R)-
ethyl 5-methyl-3-phenylpyrrolidine-2-carboxylate 13, the configuration of which was 




(2R,3R,5R)-Ethyl 5-methyl-3-phenylpyrrolidine-2-carboxylate 2-4 
The solution of (3R)-ethyl 2-nitro-5-oxo-3-phenylhexanoate 2-3a (55.8 mg, 0.2 
mmol) in methanol (3 mL) was pumped through the H-Cube
TM
 using Raney Ni as 
catalyst at 1 mL/min.  The pressure of the system was set to 40 bar and the temperature 
was set to room temperature.  The reaction was followed by TLC. When the reaction was 
completed, the mixture was concentrated and purified by flash column chromatography 
(ethyl acetate/hexanes = 1:3) to afford the desired product 2-4 (23.3 mg, 50%).  The 










Following the representative procedure illustrated in section B, the Michael addition 
of ethyl nitroacetate to trans-4-phenyl-3-buten-2-one was performed to give the adduct 2-
3a, which was fluorinated by to yield the (2S,3R)-ethyl 2-fluoro-2-nitro-5-oxo-3-
phenylhexanoate 2-5a and (2R,3R)-ethyl 2-fluoro-2-nitro-5-oxo-3-phenylhexanoate 2-5b, 




(3R)-Ethyl 2-fluoro-2-nitro-5-oxo-3-phenylhexanoate 2-5 
To a solution of (3R)-ethyl 2-nitro-5-oxo-3-phenylhexanoate 2-3a (558 mg, 21 mmol) 
in THF (8 mL) was added NaH (84 mg, 2.2 mmol) in small portions at -10 
o
C and the 
resulting mixture was stirred for 10 minutes.  Then Selectfluor (780 mg, 22 mmol) was 
added to the solution and the suspension was allowed to stir at room temperature for 24 
hours.   The reaction mixture was filtered and the filtrate was concentrated and the 
residue was purified by flash column chromatography (ethyl acetate/hexanes = 1:10) to 
afford 2-5a and 2-5b as colorless crystalline compound (483.3 mg, 82%).  The analytical 
data of 2-5 were consistent with the literature values.
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(3R)-Ethyl 2-nitro-5-oxo-3-phenylhexanoate 2-3a 
 
The diastereomeric mixture (dr = 1:1) was isolated as a white crystal; The ee value 
was 99%, 99%; anti isomer: tR (minor) = 18.24 min, tR (major) = 20.31 min; syn isomer: 
tR (major) = 28.82 min, tR (minor) = 35.90 min, (Chiralcel IC-H, λ = 254 nm, 20% 
iPrOH/hexanes, flow rate = 0.5 mL/min); 
1
H NMR (300 MHz, CDCl3) δ 1.07 (t, J = 7.1 
Hz, 3H), 1.29 (t, J = 7.2 Hz, 3H), 2.07 (s, 6H), 2.92-3.16 (m, 4H, CH2 for both 
diastereomers), 4.04 (q, J = 2.8 Hz, 1H), 4.09 (q, J = 2.9 Hz, 1H), 4.22-4.31 (m, 4H, CH2 
for both diastereomers), 5.41 (d, J = 8.7 Hz, 1H), 5.47 (d, J = 9.8 Hz, 1H), 7.24-7.30 (m, 
10H); 
13
C NMR (75 MHz, CDCl3) δ 13.5, 13.7, 30.2, 30.3, 41.2, 41.5, 45.1, 45.4, 62.9, 
63.2, 91.1, 91.2, 127.9, 128.0, 128.3, 128.8, 128.9, 136.9, 137.8, 163.0, 163.5, 204.5, 
204.7; HRMS (ESI) m/z calcd for C14H17NO5 [M+Na]
+
 302.1004, found 302.1012. 
(3R)-tert-Butyl 2-nitro-5-oxo-3-phenylhexanoate 2-3b 
 
The diastereomeric mixture (dr = 1.8:1) was isolated was purified as a white oil; The 
ee value was 92%, 94%; syn isomer: tR (minor) = 9.33 min, tR (major) = 10.43 min; anti 
isomer: tR (minor) = 13.09 min, tR (major) = 17.08 min, (Chiralcel AD-H, λ = 210 nm, 
3% iPrOH/hexanes, flow rate = 1.0 mL/min); 
1




1.46 (s, 3H), 2.05 (t, J = 2.9 Hz, 3H), 2.91-3.06 (m, 2H, CH2 for both diastereomers), 
4.20 (m, 1H), 5.33 (d, J = 9.4 Hz, 0.5H), 5.38 (d, J = 9.5 Hz, 0.5H), 7.23-7.30 (m, 5H); 
13
C NMR (75 MHz, CDCl3) δ27.4, 27.6, 30.4, 41.8, 45.7, 84.7, 92.1, 128.1, 128.6, 128.9, 
137.0, 162.0, 204.7; HRMS (ESI) m/z calcd for C16H21NO5 [M+Na]
+
 330.1323, found 
330.1325. 
 
(3R)-benzyl 2-nitro-5-oxo-3-phenylhexanoate 2-3c 
 
The diastereomeric mixture (dr = 1:1) was purified as a white oil; The ee value was 
96%, 95%; syn isomer: tR (minor) = 21.80 min, tR (major) = 28.70 min; anti isomer: tR 
(minor) = 23.25 min, tR (major) = 31.79 min, (Chiralcel AD-H, λ = 210 nm, 3% 
iPrOH/hexanes, flow rate = 1.0 mL/min); 
1
H NMR (300 MHz, CDCl3) δ2.03 (s, 3H), 
2.87-3.14 (m, 2H, CH2 for both diastereomers), 4.26 (m, 1H), 5.03 (d, J = 2.5 Hz, 1H), 
5.22 (d, J = 2.0 Hz, 1H), 5.46 (d, J = 8.7 Hz, 0.5H), 5.52 (d, J = 9.4 Hz, 0.5H), 7.12-7.38 
(m, 10H); 
13
C NMR (75 MHz, CDCl3) δ30.2, 30.3, 41.3, 41.6, 45.0, 45.2, 68.5, 68.6, 91.0, 
91.2, 128.0, 128.1, 128.3, 128.5, 128.6, 128.7, 128.8, 128.9, 129.0, 133.9, 134.1, 136.7, 








 (3R)-Ethyl 3-(4-chlorophenyl)-2-nitro-5-oxohexanoate 2-3e 
 
The diastereomeric mixture (dr = 1.6:1) was isolated as a pale yellow oil; The ee 
value was 76%, 95%; syn isomer: tR (minor) = 13.65 min, tR (major) = 18.23 min; anti 
isomer: tR (minor) = 16.51 min, tR (major) = 19.00 min, (Chiralcel AD-H, λ = 210 nm, 
5% iPrOH/hexanes, flow rate = 1.0 mL/min); 
1
H NMR (300 MHz, CDCl3) δ1.15 (t, J = 
7.2 Hz, 3H), 1.33 (t, J = 7.2 Hz, 3H), 2.14 (s, 6H), 3.00-3.12 (m, 4H, CH2 for both 
diastereomers), 4.15 (q, J = 7.1 Hz, 2H), 4.27-4.31 (m, 4H, CH2 for both diastereomers), 
5.43 (d, J = 8.6 Hz, 1H), 5.49 (d, J = 10.4 Hz, 1H), 7.20-7.30 (m, 8H); 
13
C NMR (75 
MHz, CDCl3) δ13.6, 13.8, 30.2, 30.3, 40.6, 40.8, 45.0, 45.3, 63.1, 63.3, 90.8, 90.9, 126.3, 
127.1, 128.6, 129.1, 129.3, 129.5, 129.7, 132.5, 133.3, 135.5, 136.2, 136.9, 141.3, 142.6, 
199.5, 204.5; HRMS (ESI) m/z calcd for C14H15NO5Cl [M]
-
 312.0644, found 312.0637. 
(3R)-Ethyl 3-(4-bromophenyl)-2-nitro-5-oxohexanoate 2-3f 
 
The diastereomeric mixture (dr = 1.3:1) was isolated as a pale yellow oil; The ee 
value was 95%, 98%; syn isomer: tR (minor) = 18.91 min, tR (major) = 25.93 min; anti 
isomer: tR (minor) = 23.84 min, tR (major) = 27.51 min, (Chiralcel AD-H, λ = 210 nm, 
3% iPrOH/hexanes, flow rate = 1.0 mL/min); 
1




7.2 Hz, 3H), 1.33 (t, J = 7.2 Hz, 3H), 2.12 (s, 6H), 3.01-3.07 (m, 4H, CH2 for both 
diastereomers), 4.14 (q, J = 7.1 Hz, 2H), 4.25-4.31 (m, 4H, CH2 for both diastereomers), 
5.42 (d, J = 8.6 Hz, 1H), 5.48 (d, J = 9.4 Hz, 1H), 7.16-7.20 (m, 4H), 7.46-7.50 (m, 4H); 
13
C NMR (75 MHz, CDCl3) δ13.6, 13.8, 30.2, 30.3, 40.7, 40.9, 45.0, 45.2, 63.1, 63.3, 
90.7, 90.8, 122.1, 129.8, 130.1, 132.0, 136.0, 136.8,162.6, 163.3, 204.3, 204.4; HRMS 
(ESI) m/z calcd for C14H15NO5Br [M]
-
 356.0139, found 356.0134. 
 
(3R)-Ethyl 3-(4-methoxyphenyl)-2-nitro-5-oxohexanoate 2-3g 
 
The diastereomeric mixture (dr = 1.1:1) was isolated as a pale yellow oil; The ee 
value was 92%, 97%; syn isomer: tR (minor) = 22.46 min, tR (major) = 28.64 min; anti 
isomer: tR (minor) = 24.31 min, tR (major) = 30.34 min, (Chiralcel AD-H, λ = 210 nm, 
10% iPrOH/hexanes, flow rate = 0.5 mL/min); 
1
H NMR (300 MHz, CDCl3) δ1.13 (t, J = 
7.2 Hz, 3H), 1.33 (t, J = 7.2 Hz, 3H), 2.10 (s, 6H), 2.97-3.04 (m, 4H, CH2 for both 
diastereomers), 3.80 (s, 6H), 4.12 (q, J = 7.1 Hz, 2H), 4.23-4.31 (m, 4H, CH2 for both 
diastereomers), 5.40 (d, J = 8.7 Hz, 1H), 5.46 (d, J = 9.5 Hz, 1H), 6.84-6.88 (m, 4H), 
7.19-7.23 (m, 4H); 
13
C NMR (75 MHz, CDCl3) δ13.6, 13.8, 30.3, 30.4, 40.6, 40.9, 45.3, 
45.5, 55.2, 62.9, 63.2, 91.4, 114.3, 128.6, 129.1, 129.4, 129.5, 159.2, 159.3, 163.1, 163.6, 
204.8, 205.0; HRMS (ESI) m/z calcd for C15H19NO6 [M+Na]
+





(3R)-Ethyl 2-nitro-3-(4-nitrophenyl)-5-oxohexanoate 2-3h 
 
The diastereomeric mixture (dr = 1:1) was isolated as a pale yellow oil; The ee value 
was 98%, 94%; syn isomer: tR (minor) = 22.12 min, tR (major) = 35.00 min; anti isomer: 
tR (minor) = 32.81 min, tR (major) = 40.96 min, (Chiralcel AD-H, λ = 210 nm,10% 
iPrOH/hexanes, flow rate = 1.0 mL/min); 
1
H NMR (300 MHz, CDCl3) δ1.18 (t, J = 7.2 
Hz, 3H), 1.31 (t, J = 7.1 Hz, 3H), 2.15 (s, 6H), 3.05-3.15 (m, 4H, CH2 for both 
diastereomers), 4.17 (q, J = 7.1 Hz, 2H), 4.30-4.41 (m, 4H, CH2 for both diastereomers), 
5.50 (d, J = 8.2 Hz, 1H), 5.57 (d, J = 9.4 Hz, 1H), 7.49-7.53 (m, 4H), 8.20-8.23 (m, 4H); 
13
C NMR (75 MHz, CDCl3) δ13.6, 13.7, 30.1, 30.2, 40.7, 40.9, 44.7, 44.9, 63.3, 63.6, 
90.2, 123.9, 124.0, 129.3, 129.5,144.6, 145.1, 147.5, 162.5, 162.9, 203.9; HRMS (ESI) 
m/z calcd for C14H15N2O7 [M]
-
 323.0885, found 323.0880. 
 





The diastereomeric mixture (dr = 1.6:1) was isolated as a pale yellow oil; The ee 
value was 90%, 93%; syn isomer: tR (minor) = 17.95 min, tR (major) = 24.30 min; anti 
isomer: tR (minor) = 22.01 min, tR (major) = 25.67 min, (Chiralcel AD-H, λ = 210 nm, 
3% iPrOH/hexanes, flow rate = 1.0 mL/min); 
1
H NMR (300 MHz, CDCl3) δ1.16 (t, J = 
7.2 Hz, 3H), 1.33 (t, J = 7.2 Hz, 3H), 2.13 (s, 6H), 2.99-3.07 (m, 4H, CH2 for both 
diastereomers), 4.14 (q, J = 7.2 Hz, 2H), 4.27-4.32 (m, 4H, CH2 for both diastereomers), 
5.42 (d, J = 8.5 Hz, 1H), 5.49 (d, J = 9.5 Hz, 1H), 7.23-7.35 (m, 8H); 
13
C NMR (75 MHz, 
CDCl3) δ13.6, 13.7, 30.1, 30.2, 40.6, 40.7, 44.7, 44.9,60.3,  63.3, 63.6, 90.3,122.8, 123.0, 
123.1, 129.8, 135.0, 135.1, 139.3, 139.9, 148.3, 162.6, 163.0, 204.0; HRMS (ESI) m/z 
calcd for C14H15NO5Cl [M]
-




(3R)-Ethyl 2-nitro-3-(2-nitrophenyl)-5-oxohexanoate 2-3j 
 
The diastereomeric mixture (dr = 1:1) was isolated as a pale yellow oil; The ee value 
was 96%, 97%; syn isomer: tR (minor) = 13.30 min, tR (major) = 16.19 min; anti isomer: 
tR (minor) = 14.76 min, tR (major) = 18.82 min, (Chiralcel AD-H, λ = 210 nm, 3% 
iPrOH/hexanes, flow rate = 1.0 mL/min); 
1




Hz, 3H), 1.32 (t, J = 7.1 Hz, 3H), 2.14 (d, J = 7.7 Hz,  6H), 3.14-3.31 (m, 4H, CH2 for 
both diastereomers), 4.23-4.32 (m, 4H, CH2 for both diastereomers), 4.75-4.83 (m, 2H), 
5.72 (q, J = 9.4 Hz, 1H), 5.84 (q, J = 13.0 Hz, 1H), 7.38-7.59 (m, 8H); 
13
C NMR (75 
MHz, CDCl3) δ13.6, 13.7, 29.9, 30.4, 36.0, 43.6, 44.1, 51.0, 63.4, 65.6, 88.9, 90.3, 124.3, 
125.2, 125.3, 128.1,128.2, 128.9, 129.0, 132.3,132.4, 133.1, 133.2, 133.8,  162.9, 204.2, 
204.4; HRMS (ESI) m/z calcd for C14H15N2O7 [M]
-
 323.0885, found 323.0879. 
 
(3R)-Ethyl 3-(2-(trifluoromethyl)phenyl)-2-nitro-5-oxohexanoate 2-3k 
 
The diastereomeric mixture (dr = 1.2:1) was isolated as a pale yellow oil; The ee 
value was 96%, 97%; syn isomer: tR (minor) = 8.69 min, tR (major) = 12.44 min; anti 
isomer: tR (minor) = 9.69 min, tR (major) = 13.40 min, (Chiralcel AD-H, λ = 210 nm, 3% 
iPrOH/hexanes, flow rate = 1.0 mL/min); 
1
H NMR (300 MHz, CDCl3) δ1.23 (t, J = 7.1 
Hz, 3H), 1.31 (t, J = 7.1 Hz, 3H), 2.13 (d, J = 4.4 Hz, 6H), 3.11-3.26 (m, 4H, CH2 for 
both diastereomers), 4.23-4.31 (m, 4H, CH2 for both diastereomers), 4.68 (q, J = 17.8 Hz, 
2H), 5.69 (d, J = 6.1 Hz, 1H), 5.83 (d, J = 8.9 Hz, 1H), 7.20-7.30 (m, 8H); 
13
C NMR (75 
MHz, CDCl3) δ13.6, 13.7, 30.0, 30.2, 36.7, 44.1, 45.2, 63.2, 89.2, 90.6, 122.2, 122.3, 




136.4, 137.0, 163.0, 163.6, 204.5; HRMS (ESI) m/z calcd for C15H16NO5F3 [M+Na]
+
  
370.0873, found 370.0867. 
 
Ethyl 2-nitro-2-((R)-3-oxocyclohexyl)acetate 2-3l 
 
The diastereomeric mixture (dr = 1:1) was isolated as a white oil; The ee value was 
96%, 93%; syn isomer: tR (minor) = 46.34 min, tR (major) = 52.67 min; anti isomer: tR 
(minor) = 50.87 min, tR (major) = 76.52 min, (Chiralcel AD-H, λ = 210 nm, 5% 
iPrOH/hexanes, flow rate = 0.5 mL/min); 
1
H NMR (300 MHz, CDCl3) δ1.32 (t, J = 6.1 
Hz, 3H), 1.57-2.49 (m, 8H), 2.79 (m, 1H), 4.29-4.32 (m, 2H, CH2 for both diastereomers), 
5.01 (d, J = 6.6 Hz, 0.5H), 5.05 (d, J = 6.9 Hz, 0.5H); 
13
C NMR (75 MHz, CDCl3) δ13.9, 
21.5, 24.0, 24.1, 26.5, 27.1, 27.2, 29.3, 29.7, 30.8, 31.9, 38.9, 40.7, 43.1, 45.7, 63.2, 91.0, 
91.2, 117.2, 126.7, 127.7, 129.6, 134.8, 162.8, 162.9, 210.8; HRMS (ESI) m/z calcd for 
C10H14NO5 [M]
-
 228.0877, found 228.0884. 
 





The diastereomeric mixture (dr = 1:1) was isolated as a white oil; The ee value was 
96%, 99%; anti isomer: tR (minor) = 20.87 min, tR (major) = 24.08 min; syn isomer: tR 
(major) = 33.36 min, tR (minor) = 37.48 min, (Chiralcel AD-H, λ = 210 nm, 5% 
iPrOH/hexanes, flow rate = 1.0 mL/min); 
1
H NMR (300 MHz, CDCl3) δ1.35 (t, J = 7.2 
Hz, 3H), 1.48-1.66 (m, 3H), 1.92-2.08 (m, 3H), 2.52-2.83 (m, 5H), 4.30-4.39 (m, 2H, 
CH2 for both diastereomers), 5.06 (d, J = 7.4 Hz, 0.5H), 5.09 (d, J = 5.9 Hz, 0.5H); 
13
C 
NMR (75 MHz, CDCl3) δ13.9, 24.0, 24.2, 28.3, 32.4, 36.9, 43.4, 43.5, 45.1, 45.3, 63.2, 
91.8, 163.1, 163.3, 210.6, 210.7; HRMS (ESI) m/z calcd for C11H17NO5 [M+Na]
+
 





Chapter 3    Primary Amine/CSA Ion Pair: A Powerful 
Catalytic System for the Asymmetric Enamine Catalysis 
 
3.1    Introduction 
3.1.1    Primary Amine Chiral Acid Catalytic System  
Aminocatalysis via the enamine mechanism has been well-established in the field of 
asymmetric synthesis and catalysis.
291-294,295,296
  Ever since the seminal discovery by List, 
Barbas and Lerner on the proline-catalyzed intermolecular aldol reaction in 2000,
297
  
proline and its structural analogues have been utilized extensively in a wide range of 
asymmetric organic reactions.  Pyrrolidine-based secondary amine catalysts were found 
to be extremely powerful in activating carbonyl substrates, aldehydes in particular, via 
the enamine intermediates.  In the past few years, primary amines have received much 
attention in the aminocatalysis.
121,164,254-256,298
  Notably, ketones have been shown to be 
suitable substrates for the primary amine-based enamine activation, which complements 
well with secondary amine-derived catalysts in this important mode of activation.  Our 
group has been investigating primary amine-mediated enamine processes in the past few 
years.
236,238,264-266,268,270
  While we have achieved a certain degree of success in a number 
of asymmetric reactions, we indeed felt the intrinsic limitation of chiral structural 
scaffolds in stereocontrol posed restriction to the effectiveness of our catalytic reactions. 





Asymmetric counteranion-directed catalysis (ACDC) was recently introduced by 
List and co-workers as a powerful strategy in asymmetric catalysis.
139-142,299-303
  The 
introduction of a chiral counteranion to the catalytic system enables reactions which 
proceeded through cationic intermediates to be conducted in a highly enantioselective 
manner; stereochemical control could be effectively induced by the chiral couteranion.
  
To the best of our knowledge, efficient catalytic systems engaging chiral counteranions 
for the enamine catalysis are yet to be developed.  We recently showed that the 
combination of 9-amino(9-deoxy)epi-cinchonine and (+)-camphorsulfonic acid (CSA) 
yielded a new primary amine-based organocatalyst useful for iminium ion activation of 
-unsaturated ketones.304  We reasoned the introduction of a chiral counteranion to the 
existing catalyst may result in a more efficient catalytic system for the enamine activation.  
Thus, a chiral diamine
305
 and a chiral acid were selected for the creation of a new ion pair 
catalyst (Figure 1).
151,155,306
  Such catalytic systems can be easily derived via modular 
assembly of the amino and the acid components.  The resulting ammonium moiety in the 
ion pair catalyst serves as a Brønsted acid to interact with the substrate.  Moreover, the 
presence of a chiral counteranion may further enhance the chiral communications 
between the chiral diamine and the substrates.  Comparing to the currently existing chiral 
primary amine catalysts, which rely on the structural scaffolds of chiral amines for the 
asymmetric induction, the proposed ion pair catalyst engages an extra chiral counteranion 
for the stereocontrol.  We hypothesize judicious selection of the two chiral components 
may create a powerful chiral diamine acid catalyst for the effective enamine catalysis.  In 




primary amine and chiral CSA result in a powerful ion pair catalyst for the enamine 
activation. 
 
Figure 3.1    Primary amine chiral acid catalytic system for the enamine catalysis. 
 
3.1.2    Synthesis of-Alkylated Phenylglycine Derivatives by Direct Amination 
of Branched Aldehydes 
Modified peptides are used extensively in medicinal chemistry and biological 
sciences,
307,308
 thus, asymmetric synthesis of optically enriched unnatural amino acids has 
been an actively pursued research area in the past few decades.
309,310
  In this context, -
disubstituted -amino acids are of extreme importance; the presence of a quaternary 
carbon center renders these unnatural amino acids increased protelytic stability, and they 
have been employed as inhibitors to probe enzymatic mechanisms.
  
Moreover, their 
incorporation into peptides provides conformational restrictions to the resulting 
peptides.
311-318
  In particular, the derivatives of -alkylated phenylglycine have been 
shown to be selective group I/group II metabotropic glutamate receptor antagonists,
319,320
 




significance, an efficient and practical synthesis of this type of unnatural amino acids is 
highly desirable. 
To demonstrate the power of diamine chiral acid ion pair catalysts in the enamine 
catalysis, and to develop an efficient synthesis of -alkylated phenylglycine derivatives, 
we turned our attention to the direct amination of branched aldehydes.  In 2002, List and 
Jørgensen disclosed their pioneering studies on the proline-catalyzed asymmetric -
amination of aldehydes.
156,157
  Shortly after, Bräse showed that proline could catalyze 
amination of -disubstituted aldehydes with moderate enantioselectivity.168  Recently, 
the same group reported an improved protocol employing microwave irradiation.
169,171,321
  
Proline-derived thiourea was also utilized by Wang et al. for the same reaction.
322
  Very 
recently, Maruoka disclosed an organocatalytic conjugate addition of heterosubstituted 
aldehydes to vinyl sulfones for the construction of -dialkylamino aldehydes.323  Our 
group recently reported a primary amine-mediated conjugate addition of branched 
aldehydes to vinyl sulfone for the asymmetric creation of quaternary carbon centers.
267-
269,280,324-330
  Given the steric hindrance of -branched aldehydes, we reasoned primary 
amines may serve as suitable catalysts for the activation of such challenging substrates in 
the enamine catalysis, and herein we demonstrate our novel ion pair catalyst with chiral 






3.2    Results and Discussion 
3.2.1    Catalyst and Solvent Screening 
We began our investigation by choosing the amination reaction of 2-phenylpropanal 
3-1 with di-tert-butyl azodicarboxylate 3-2 (DBAD) as a model reaction, and the catalytic 
effects of various primary amine catalysts were studied (Table 3.1).  Different amino 
acids, L-serine-derived 53, L-threonine-derived 54, and diamine-based 64, were found to 
be effective, affording the desired products in moderate yields and enantioselectivities 
(entries 1-3).  9-Amino(9-deoxy)epi-cinchonidine 61, in combination with different acids, 
could promote the amination, and good chemical yield and enantioselectivity were 
achieved when TFA was employed (entry 6).  However, the inclusion of methanesulfonic 
acid (MsOH), p-toluenesulfonic acid (TsOH) or trifluoromethanesulfonic acid (TfOH) in 
the catalytic system turned to be ineffective (entries 7-10).
331
  To our delight, the 
introduction of a chiral CSA resulted in highly efficient catalytic systems (entries 11,12).   
The (+)-CSA/61 ion pair induced better enantioselectivity than the (-)-CSA/61 ion pair; 
this made us think the chirality matching between the diamine and CSA may play an 
important role in the stereocontrol.  The use of 9-amino(9-deoxy)epi-quinine 25 with 
CSA led to further improvement, and the (-)-CSA/25 ion pair afforded the desired 
amination product in quantitative yield and with 97% ee (entry 14).  The molar 
equivalence of CSA to diamine 25 can be varied, but more than 2 equivalences of CSA 
were found to be detrimental (entries 15-18).  Mixing 9-amino(9-deoxy)epi-cinchonine 
38 or 9-amino(9-deoxy)epi-qunidine 62 with chiral CSA resulted in mis-matched chiral 




suggesting the stereochemical outcome of the reaction was mainly controlled by the 
chiral scaffolds of cinchona alkaloid (entries 19-22). 
Table 3.1    Screening of Chiral Primary Amines/Acids for the Amination of 2-











1 53 none 74 -77  
2 54 none 57 -60  
3 64 none 73 76  
4 61 benzoic acid 50 49 
5 61 4-NO2-PhCOOH 47 75 




7 61 MsOH 30 88 
8 61 TsOH.H2O <10 - 
9 61 TsOH  <10 - 
10 61 TfOH <10 - 
11 61 (+)-CSA 90 93 
12 61 (-)-CSA 99 87 
13 25 (+)-CSA 98 91 













19 38 (+)-CSA 96 -14 
20 38 (-)-CSA 99 -13 
21 62 (+)-CSA 83 -26 




Reaction conditions: di-tert-butyl azodicarboxylate 3-2a (0.1 mmol), 2-phenylpropanal 3-





 Determined by 
1






With 0.02 mmol acid. 
e
 With 0.03 mmol acid. 
f 
With 0.045 mmol acid. 
g
 With 0.05 mmol acid.  
h
 
„+‟ ee value and „-‟ ee value mean two enatioisomers. 
 
3.2.2    Reaction Scope 
3.2.2.1    Azodicarboxylates Screening  
The influence of different ester moieties in the azodicarboxylates on the reactions 
was next investigated (Scheme 3.1).  Di-isopropyl azodicarboxylate offered slightly 
decreased enantioselectivity, and the employment of di-benzyl azodicarboxylate led to 
substantial decrease in enantioselectivity.  Thus, DBAD was used as the aminating 
reagent for our following studies.  
Scheme 3.1    The Effects of Different Azodicarboxylates 
 
 
3.2.2.2    Branched Aldehydes Screening  
Having identified the best catalytic system, we next proceeded to examine the 




other -alkyl-substituted phenylglycines could be prepared in excellent yields and with 
nearly perfect enantioselectivities (entries 1-3).  The reaction proved to be versatile for 
the synthesis of various aryl-substituted phenylglycine analogues; a wide range of 2-
arylpropanals could be employed, and very high chemical yields and excellent 
enatioselectivities were attainable (entries 4-15).  Notably, this reaction could even offer 
certain degree of stereochemical differentiation between the two alkyl groups, -
methylpentanal could be aminated with 68% ee (entry 16). 














1 Ph/Me 3-3a 99 97 
2 Ph/Et 3-3d 91 99 
3 Ph/iPr 3-3e 95 96 
4 1-naphthyl/Me 3-3f 97 98 
5 2-naphthyl/Me 3-3g 97 97 
6 2-BrC6H4/Me 3-3h 92 99 
7 2-NO2C6H4/Me 3-3i 80 96 




9 3-BrC6H4/Me 3-3k 83 97 
10 3- NO2C6H4/Me 3-3l 99 95 
11 3,5-OMeC6H3/Me 3-3m 99 99 
12 4-BrC6H4/Me 3-3n 99 96 
13 4-NO2C6H4/Me 3-3o 82 96 
14 4-MeC6H4/Me 3-3p 85 99 
15 4-OMeC6H4/Me 3-3q 99 97 
16 Pr/Me 3-3r 99 68 
 
a
 Reaction conditions: di-tert-butyl azodicarboxylate 3-2a (0.1 mmol), aldehyde 3-1 (0.15 





Determined by HPLC analysis on a chiral stationary phase. 
 
3.2.3    Lowering the Catalyst Loading  
The turnover numbers of organocatalytic reactions are in general lower than those of 
transition metal-mediated processes, and high catalyst turnovers are certainly ideal for the 
industrial applications.  The feasiblility of reducing our catalyst loading to a very 
practical level was examined (Table 3.3).  The loading of diamine 25 could be reduced to 
1 mol % with little effects on the chemical yield and enantioselectivity (entry 3).  When 




the reaction were virtually maintained, although a longer reaction time was required 
(entry 4). 
 











1 20 24 99 97  
2 10 24 99 97  
3 1 24 99 96 
4 0.5 36 96 95 
5 0.1 72 47 3 
 
a 
Reaction conditions: di-tert-butyl azodicarboxylate 3-2a (0.1 mmol), aldehyde 3-1 (0.15 









3.3    Synthesis of -methyl Phenylglycine 
To demonstrate the value of our catalytic asymmetric synthetic method in the 
scaleable synthesis of unnatural -disubstituted amino acids, a gram-scale synthesis of 
-methyl phenylglycine was performed (Scheme 3.2).  Aldehyde 3-3a, prepared via our 
amination protocol with only 0.5 mol % catalyst loading, was readily converted into 
methyl ester 3-4. The N-N bond was cleaved by treating with SmI2, and the N-Boc -
methyl phenylglycine 3-5 was obtained in good yield at a gram scale. 
Scheme 3.2    A Gram-scale Synthesis of -methyl Phenylglycine 
 
 
3.4    Conclusion 
In conclusion, we designed novel ion pair catalysts containing a chiral counteranion 
for the enamine catalysis for the first time, and such catalysts can be easily derived by 
simply mixing cinchona alkaloid-derived diamine with chiral CSA.  Our ion-pair 
catalysts were found to be very effective in promoting the direct amination reactions of 
-branched aldehydes.  A mixture of 9-amino(9-deoxy)epi-quinine 25 and (-)-CSA was 
shown to be the best catalyst with matching chirality, affording the desired amination 
product in quantitative yield and nearly perfect enantioselectivity.  Remarkably, a catalyst 




and stereoselectivity.  A gram-scale asymmetric synthesis of biologically important -
methyl phenylglycine was realized, suggesting the great potential of the chiral ion-pair 
catalyst for industrial applications.  We believe the novel ion-pair catalysts described in 
this report will find wide applications in the enamine catalysis, and we are currently 
extending their applications to other important organic transformations.  
 
3.5    Experimental Section 




C NMR spectra were recorded on a Bruker ACF300 or DPX300 (300 MHz) 
or AMX500 (500 MHz) spectrometer. Chemical shifts were reported in parts per million 
(ppm), and the residual solvent peak was used as an internal reference. Multiplicity was 
indicated as follows: s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), dd 
(doublet of doublet), br s (broad singlet). Coupling constants were reported in Hertz (Hz). 
Low resolution mass spectra were obtained on a Finnigan/MAT LCQ spectrometer in ESI 
mode, and a Finnigan/MAT 95XL-T mass spectrometer in FAB mode. All high 
resolution mass spectra were obtained on a Finnigan/MAT 95XL-T spectrometer. Flash 
chromatography separation was performed on Merck 60 (0.040 - 0.063 mm) mesh silica 
gel. The enantiomeric excesses of products were determined by chiral-phase HPLC 
analysis. The hydrogenation was performed by using H-Cube
TM
.        
2-Phenylpropanal, 2-methylpentanal, 2-methylbutanal and azodicarboxylates were 






 (S)-Methyl 2-(tert-butoxycarbonylamino)-2-phenylpropanoate 3-5 




3.5.2    Representative Procedure for the Direct Amination Reaction 
Vinylogous aldol reaction of 3,4-dichloro-2-(5H)-furanone 3-1a with t-butyl 
phenylglyoxylate 3-2c catalyzed by 25 
 
Di-tert-butyl azodicarboxylate 3-2a (23.0 mg, 0.1 mmol) was added to a mixture of 
9-amino(9-deoxy)epi-quinine 25 (2.9 mg, 0.01 mmol),  (-)-CSA (4.6 mg, 0.02 mmol) and 
2-phenylpropanal 3-1a (20 μl, 0.15 mmol) in chloroform (0.2 mL) in a sample vial at 
room temperature.  The vial was then sealed and the reaction mixture was stirred at room 
temperature for 24 hours.  Then the solvent was concentrated in vacuo, and the residue 
was purified by flash column chromatography (ethyl acetate/hexanes = 1:10) to afford the 
desired product as a colorless oil (36.3 mg, 99% yield).  The enantiometric excess of 





3.5.3    Determination of Absolute Configurations of the Products 
Compound 3-5 was synthesized following the literature procedure,
169,322,332 
and the 






A colorless oil ( 67% overall yield from 3-3a); 
1
H NMR (300 MHz, CDCl3) δ 1.30 (s, 
9H), 1.88 (s, 3H), 3.99 (s, 1H), 7.26-7.46 (m, 5H); [α]D = -19.0 (c = 1.00, CHCl3). 
Comparing to the [α]D of known (R)-methyl 2-(tert-butoxycarbonylamino)-2-
phenylpropanoate reported in the literature ([α]D
23
 = +40.6 (c 1.3, CHCl3)),
2 
 the 
configuration 3-5 was assigned as S, and the configurations of other amination products 
were assigned by analogy.  
 
3.5.4    Analytical Data of the Amination Products 





A colorless oil; 99% yield and 97% ee; tR (minor) = 31.54 min, tR (major) = 38.49 
min (Chiralcel AD-H, λ = 220 nm, 10% iPrOH/hexanes, flow rate = 0.5 mL/min); 1H 
NMR (300 MHz, CDCl3) δ1.40 (s, 18H), 1.70 (s, 3H), 6.59 (br. s, 1H, NH rotamers), 
7.24-7.51 (m, 5H), 9.54, 9.66 (2s, 1H, CHO rotamers);  
13
C NMR (75 MHz, CDCl3) δ 
17.7, 18.6, 27.9, 28.0, 72.8, 81.4, 83.0, 126.7, 127.8, 128.4, 128.7, 137.5, 155.1, 155.7, 
193.1;  [α]D = -47.1 (c = 1.00, CHCl3);  HRMS (ESI) m/z calcd for C19H28N2O5 [M+Na]
+
 
387.1890, found 387.1901. 
 
(S)-Di-tert-butyl 1-(1-oxo-2-phenylbutan-2-yl)hydrazine-1,2-dicarboxylate (3-3d)  
 
A colorless oil; 91% yield and 99% ee; tR (minor) = 26.04 min, tR (major) = 34.74 
min (Chiralcel AD-H, λ = 220 nm, 10% iPrOH/hexanes, flow rate = 0.5 mL/min); 1H 
NMR (300 MHz, CDCl3) δ 1.30-1.55 (m, 21H, CH2CH3, C(CH3)3 rotamers), 2.16-2.53 
(m, 2H, RCH2R), 6.19 (br. s, 1H, NH rotamers), 7.38-7.65 (m, 5H), 9.60, 9.82 (2s, 1H, 
CHO rotamers); 
13
C NMR (125 MHz, CDCl3) δ 7.5, 21.8,  28.2,, 73.3, 80.9, 82.9, 124.9, 
125.9, 126.2, 129.5, 136.3, 141.0, 154.7, 193.2; [α]D = -10.3 (c = 1.00, CHCl3); HRMS 
(ESI) m/z calcd for C20H30N2O5 [M+Na]
+






dicarboxylate (3-3e)  
 
A colorless oil; 95% yield and 96% ee; tR (minor) = 20.00 min, tR (major) = 23.43 
min (Chiralcel AD-H, λ = 220 nm, 10% iPrOH/hexanes, flow rate = 0.5 mL/min); 1H 
NMR (300 MHz, CDCl3) δ 0.76-1.01 (m, 6H, CH(CH3)2 rotamers), 1.27-1.72 (m, 19H, 
CH(CH3)3, C(CH3)3 rotamers), 2.02-2.39(m, 2H), 6.24, 6.36 (br. s, 1H, NH rotamers), 
7.28-7.70 (m, 5H), 9.67, 9.94 (2s, 1H, CHO rotamers); 
13
C NMR (75 MHz, CDCl3) δ 
14.0, 24.4, 27.7, 28.1, 41.0, 75.1, 82.7, 126.7, 127.5, 128.3, 154.5, 193.9; [α]D = -63.2 (c 
= 1.00, CHCl3); HRMS (ESI) m/z calcd for C22H34N2O5 [M+Na]
+




dicarboxylate (3-3f)  
 
A colorless oil; 97% yield and 98% ee; tR (minor) = 14.91 min, tR (major) = 26.65 




NMR (500 MHz, CDCl3) δ 1.39-1.47 (m, 18H, C(CH3)3 rotamers), 2.07, 2.08 (2s, 3H, 
CR3CH3 rotamers), 5.88, 6.12 (br. s, 1H, NH rotamers), 7.28-8.49 (m, 7H), 10.27 (s, 1H); 
13
C NMR (125 MHz, CDCl3) δ 19.5, 28.1, 75.1, 81.5, 83.2, 123.5, 124.3, 125.6, 125.7, 
127.1, 129.8, 131.4, 134.7, 155.1, 193.7; [α]D = -7.8 (c = 1.00, CHCl3);  HRMS (ESI) m/z 
calcd for C23H30N2O5 [M+Na]
+
 437.2047, found 437.2057. 
(S)-Di-tert-butyl 1-(2-(naphthalen-2-yl)-1-oxopropan-2-yl)hydrazine-1,2-
dicarboxylate (3-3g)  
 
A colorless oil; 97% yield and 97% ee; tR (minor) = 16.91 min, tR (major) = 31.07 
min (Chiralcel AD-H, λ = 220 nm, 10% iPrOH/hexanes, flow rate = 1.0 mL/min); 1H 
NMR (300 MHz, CDCl3) δ 1.44-1.58 (m, 18H, C(CH3)3 rotamers), 1.88 (s, 3H), 6.00, 
6.25 (br. s, 1H, NH rotamers), 7.49-7.86 (m, 7H), 9.67, 9.81 (2s, 1H, CHO rotamers); 
13
C 
NMR (125 MHz, CDCl3) δ 17.8, 28.0, 73.1, 81.6, 83.3, 124.5, 126.1, 126.4, 126.5, 127.5, 
128.3, 128.6 132.8, 133.4, 155.4, 193.0; [α]D = -27.3 (c = 1.00, CHCl3); HRMS (ESI) m/z 
calcd for C23H30N2O5 [M+Na]
+
 437.2047, found 437.2055. 
 
(S)-Di-tert-butyl 1-(2-(2-bromophenyl)-1-oxopropan-2-yl)hydrazine-1,2-





A colorless oil; 92% yield and 99% ee; tR (minor) = 23.36 min, tR (major) = 38.74 
min (Chiralcel AD-H, λ = 220 nm, 10% iPrOH/hexanes, flow rate = 0.5 mL/min); 1H 
NMR (300 MHz, CDCl3) δ 1.42-1.64 (m, 18H, C(CH3)3 rotamers), 1.77-1.89 (m, 3H, 
CR3CH3 rotamers), 6.27, 6.53 (br. s, 1H, NH rotamers), 7.19-7.66 (m, 4H), 10.20 (s, 1H, 
CHO rotamers); 
13
C NMR (125 MHz, CDCl3) δ19.7, 27.9, 72.8, 81.5, 82.9, 126.7, 128.3, 
129.6, 133.3, 135.7, 155.6, 195.7; [α]D = -19.4 (c = 1.00, CHCl3); HRMS (ESI) m/z calcd 
for C19H27BrN2O5 [M+Na]
+





A colorless oil; 80% yield and 96% ee; tR (minor) = 27.83 min, tR (major) = 29.66 
min (Chiralcel AD-H, λ = 220 nm, 10% iPrOH/hexanes, flow rate = 0.5 mL/min); 1H 
NMR (300 MHz, CDCl3) δ 1.39-1.76 (m, 21H, CR3CH3, C(CH3)3 rotamers), 6.31 (br. s, 
1H, NH rotamers), 7.42-7.95 (m, 4H), 9.89 (s, 1H); 
13
C NMR (125 MHz, CDCl3) δ22.7, 




1.00, CHCl3); HRMS (ESI) m/z calcd for C19H27N3O7 [M+Na]
+





dicarboxylate (3-3j)  
 
A colorless oil; 99% yield and 99% ee; tR (minor) = 13.74 min, tR (major) = 20.84 
min (Chiralcel OD-H, λ = 220 nm, 5% iPrOH/hexanes, flow rate = 0.5 mL/min); 1H 
NMR (300 MHz, CDCl3) δ 1.25-1.51 (m, 18H, C(CH3)3 rotamers), 1.60-1.85 (m, 3H, 
CR3CH3 rotamers), 3.84 (s, 3H), 6.04- 6.27 (br. s, 1H, NH rotamers), 6.89-7.30 (m, 4H), 
9.86-9.93 (s, 1H, CHO rotamers); 
13
C NMR (75 MHz, CDCl3) δ 19.1, 28.1, 55.7, 72.2, 
81.5, 82.2, 111.4, 121.3, 128.4, 129.7, 155.7, 156.6, 197.4; [α]D = -9.1 (c = 1.00, CHCl3); 
HRMS (ESI) m/z calcd for C20H30N2O6 [M+Na]
+
 417.1996, found 417.2006. 
 
(S)-Di-tert-butyl 1-(2-(3-bromophenyl)-1-oxopropan-2-yl)hydrazine-1,2-





A colorless oil; 83% yield and 97% ee; tR (minor) = 19.44 min, tR (major) = 31.97 
min (Chiralcel AD-H, λ = 220 nm, 10% iPrOH/hexanes, flow rate = 1.0 mL/min); 1H 
NMR (300 MHz, CDCl3) δ 1.46-1.55 (m, 18H, C(CH3)3 rotamers), 1.74 (s, 3H, CR3CH3 
rotamers), 6.30 (br. s, 1H, NH rotamers), 7.28-7.58 (m, 4H), 9.61, 9.70 (2s, 1H, CHO 
rotamers); 
13
C NMR (75 MHz, CDCl3) δ 18.8, 27.9, 28.1, 72.3, 81.9, 83.6, 128.5, 129.7, 
130.1, 131.0, 140.1, 155.5, 193.1; [α]D = -16.3 (c = 1.00, CHCl3); HRMS (ESI) m/z calcd 
for C19H27BrN2O5 [M+Na]
+





A colorless oil; 99% yield and 95% ee; tR (minor) = 16.34 min, tR (major) = 27.59 
min (Chiralcel AD-H, λ = 220 nm, 10% iPrOH/hexanes, flow rate = 2.0 mL/min); 1H 
NMR (300 MHz, CDCl3) δ 1.29-1.63 (m, 18H,  C(CH3)3 rotamers), 1.78 (s, 3H), 6.40 (br. 
s, 1H, NH rotamers), 7.58-8.48 (m, 4H), 9.69, 9.74 (2s, 1H, CHO rotamers); 
13
C NMR 




129.3, 133.0, 141.0, 148.6, 154.6, 155.6, 193.4, 193.6; [α]D = -7.8 (c = 1.00, CHCl3); 
HRMS (ESI) m/z calcd for C19H27N3O7 [M+Na]
+




dicarboxylate (3-3m)  
 
A colorless oil; 99% yield and 99% ee; tR (minor) = 38.26 min, tR (major) = 49.53 
min (Chiralcel AD-H, λ = 220 nm, 10% iPrOH/hexanes, flow rate = 0.5 mL/min); 1H 
NMR (300 MHz, CDCl3) δ 1.36-1.51 (m, 18H, C(CH3)3 rotamers), 1.62-1.84 (m, 3H, 
CR3CH3 rotamers), 3.80 (s, 6H), 6.00, 6.23 (br. s, 1H, NH rotamers), 6.46 (s, 3H), 9.89 (s, 
1H, CHO rotamers) ppm; 
13
C NMR (75 MHz, CDCl3) δ 18.8, 28.1, 55.4, 72.1, 80.8, 81.5, 
99.2, 104.7, 105.0, 128.9, 129.5, 132.7, 155.7, 155.8, 196.6; [α]D = +5.7 (c = 1.00, 
CHCl3); HRMS (ESI) m/z calcd for C21H32N2O7 [M+Na]
+
 447.2102, found 447.2112. 
 
(S)-Di-tert-butyl 1-(2-(4-bromophenyl)-1-oxopropan-2-yl)hydrazine-1,2-





A colorless oi; 99% yield and 96% ee; tR (minor) = 27.13 min, tR (major) = 32.20 
min (Chiralcel AD-H, λ = 220 nm, 10% iPrOH/hexanes, flow rate = 0.5 mL/min); 1H 
NMR (300 MHz, CDCl3) δ 1.46, 1.50 (2s, 18H, C(CH3)3 rotamers), 1.65,1.74 (2s, 3H, 
CR3CH3 rotamers), 6.28 (br. s, 1H, NH rotamers), 7.28-7.56 (m, 4H), 9.59, 9.70 (2s, 1H, 
CHO rotamers); 
13
C NMR (75 MHz, CDCl3) δ 18.2, 28.0, 72.2, 81.8, 83.4, 122.1, 128.4, 
131.8, 136.9, 155.5, 192.8; [α]D = -19.3 (c = 1.00, CHCl3); HRMS (ESI) m/z calcd for 
C19H27BrN2O5 [M+Na]
+





A colorless oil; 82% yield and 96% ee; tR (minor) = 26.65 min, tR (major) = 30.87 
min (Chiralcel AD-H, λ = 220 nm, 5% iPrOH/hexanes, flow rate = 1.0 mL/min); 1H 
NMR (500 MHz, CDCl3) δ 1.49 (s, 18H), 1.74 (s, 3H), 6.23, 6.36 (br. s, 1H, NH 
rotamers), 7.65-8.26 (m, 4H), 9.66, 9.77 (2s, 1H, CHO rotamers); 
13
C NMR (75 MHz, 











dicarboxylate (3-3p)  
 
A colorless oil; 85% yield and 99% ee; tR (minor) = 23.76 min, tR (major) = 32.41 
min (Chiralcel AD-H, λ = 220 nm, 5% iPrOH/hexanes, flow rate = 0.5 mL/min); 1H 
NMR (300 MHz, CDCl3) δ 1.48-1.62 (m, 18H, C(CH3)3 rotamers), 1.78 (s, 3H), 2.38 (s 
3H),  6.25 (br. s, 1H, NH rotamers), 7.19-7.32 (m, 4H), 9.57, 9.71 (2s, 1H, CHO 
rotamers); 
13
C NMR (125 MHz, CDCl3) δ22.7, 28.1, 29.7 70.5, 81.9, 83.4, 123.9, 127.8, 
128.2, 131.4, 148.9, 155.6, 197.4; [α]D = -19.7 (c = 1.00, CHCl3); HRMS (ESI) m/z calcd 
for C20H30N2O5 [M+Na]
+
 401.2047, found 401.2053. 
 
(S)-Di-tert-butyl 1-(2-(4-methoxyphenyl)-1-oxopropan-2-yl)hydrazine-1,2-





A colorless oil; 99% yield and 97% ee; tR (minor) = 31.30 min, tR (major) = 42.04 
min (Chiralcel AD-H, λ = 220 nm, 10% iPrOH/hexanes, flow rate = 0.5 mL/min); 1H 
NMR (300 MHz, CDCl3) δ 1.29-1.62 (m, 18H, C(CH3)3 rotamers), 1.78 (m, 3H), 3.84 (s, 
3H),  6.22 (br. s, 1H, NH rotamers), 6.91-7.49 (m, 4H), 9.56, 9.69 (2s, 1H, CHO 
rotamers); 
13
C NMR (75 MHz, CDCl3) δ 17.2, 28.0, 55.2, 72.4, 81.5, 83.0, 114.2, 128.1, 
155.1, 159.3, 192.6; [α]D = -38.1 (c = 1.00, CHCl3); HRMS (ESI) m/z calcd for 
C20H30N2O6 [M+Na]
+
 417.1996, found 417.2001. 
 
(S)-Di-tert-butyl 1-(2-methyl-1-oxopentan-2-yl)hydrazine-1,2-dicarboxylate (3-3r)  
 
A colorless oi; 99% yield and 68% ee; tR (minor) = 24.97 min, tR (major) = 32.83 
min (Chiralcel IA-H, λ = 220 nm, 5% iPrOH/hexanes, flow rate = 0.5 mL/min); 1H NMR 
(300 MHz, CDCl3) δ 0.89-0.98(m, 3H, CH2CH3, rotamers), 1.22-1.36 (m, 5H, CH2CH3, 
CR3CH3, rotamers), 1.47, 1.52 (2s, 18H, C(CH3)3 rotamers), 1.65-1.86 (m, 2H), 6.27 (br. 
s, 1H, NH rotamers), 9.55 (s, 1H, CHO rotamers); 
13
C NMR (75 MHz, CDCl3) δ 14.5, 
16.9, 28.1, 29.7, 36.1, 69.3, 81.5, 82.7, 154.8, 155.8, 198.1, 198.9; [α]D = -3.7 (c = 1.00, 
CHCl3); HRMS (ESI) m/z calcd for C16H30N2O5 [M+Na]
+










Chapter 4    Organocatalytic Asymmetric Aldol Reaction of 
Acetone and Hydroxyacetone with -Unsaturated -Keto 
Esters: Facile Access to Chiral Tertiary Alcohols 
 
4.1    Introduction 
Creation of quaternary stereogenic centers is a challenging task in organic synthesis 
and has drawn enormous attention in the past few decades.
334
  As our continuous efforts 
in developing efficient asymmetric organocatalytic methods for the synthesis of chiral 
quaternary carbons, we had recently become interested in efficient preparation of organic 
molecules containing a tertiary alcohol group.
267-269,280,324-328
  Tertiary alcohols play very 
important roles in the pharmaceutical industry and biological sciences.
335-338
  In this 
context, glycerol derivatives containing a quaternary center are key motifs in many 
pharmaceutical agents, as well as versatile intermediates useful in organic synthesis.
339-341
  
Despite their importance, asymmetric methods for the synthesis of glycerol derivatives 
bearing a quaternary center are very limited.
342-349
  Harada and Oku described a synthesis 
in which menthon was utilized as a chiral auxiliary.
350
  Recently, Kang et al. employed 
chiral copper complexes to achieve an enantioselective desymmetrization of meso-2-
substituted glycerol and prepared high enantioselective 2-substituted 1,2,3-
propanetriols.
351,352
  Very recently, our group disclosed highly diastereoselective and 




provide easy access to chiral glycerol derivatives containing a tertiary alcohol moiety.
328
  
Given the importance of chiral glycerol derivatives and the limited methods for their 
preparation, their efficient synthesis is still highly sought. 
In designing an efficient process to access chiral substituted glycerol, we turned our 
attention to the direct aldol reaction between hydroxyacetone and -unsaturated -keto 
esters. -Keto esters are valuable electrophiles in organic synthesis, and they have been 
extensively investigated in a range of asymmetric organic transformations in recent years. 
269,353-361
  On the other hand, the utilization of -unsaturated -keto esters in the direct 
asymmetric organocatalytic aldol reaction is rare. Zhao and co-workers successfully 
employed cyclic ketones in an organocatalytic aldol reaction with -unsaturated -
ketoesters.
362,363
  Subsequently, Chan and Kwong developed an asymmetric aldol reaction 
between ketones and -unsaturated -ketoesters, it is noteworthy that both cyclic and 
acyclic ketones bearing long carbon side chains were suitable substrates in their 
studies.
364,365
   Hydroxyacetone is a useful donor, and its applications in the aldol reaction 
have been well studied.
198,228
  For the construction of chiral glycerol derivatives, we 
envisioned that a direct aldol reaction between hydroxyacetone and -unsaturated -
keto esters may be utilized (Scheme 4.1). Given the availability of organocatalytic 
synthetic methods, the chiral glycerol skeleton can be readily created via the projected 
direct aldol reaction. Moreover, the aldol products possess rich functionalities, e.g. alkene, 
ester and ketone, which would allow their ready conversion to various glycerol 
derivatives containing a tertiary alcohol group. Herein, we document a highly 




which provides an easy access to chiral glycerol derivatives containing a quaternary 
stereogenic center. 
Scheme 4.1    Construction of Glycerol Derivatives through Direct Aldol Reaction. 
 
 
4.2    Results and Discussion 
4.2.1    Catalyst Screening for Acetone as Donor of Aldol Reaction 
We initially chose the reaction between acetone 4-1a and methyl 2-oxo-4-phenylbut-
3-enoate 4-2a as a model reaction, and the catalytic effects of various primary amine 
catalysts were examined, and the results are summarized in Table 4.1.  Different amino 
acids and derivatives, were found to be effective, affording the desired products in 
moderate yields, low enantioselectivities and poor diastereoselectivity (entries 1-13).  
Primary amine with a free hydroxyl group catalysts, as well as (1S,2S)-1,2-
diphenylethane-1,2-diamine 80 and its derivatives were also tested in the reaction (entry 


























1 65 41 15 
2
 
66 3 13 
3 67 36 -31 
4 68 70 17 
5 
d
 69 22 14 
6 70 70 -11 
7 
e
 71 10 22 
8 72 51 19 
9 73 10 16 
10 53 >99 29 
11 74 13 -17 
12 75 95 35 
13 76 99 44 
14
 
77 47 23 
15 78 21 -18 
16 79 35 -20 
17 80 73 <5 
18 81 33 -5 
19 64 95 27 
20 59 52 -6
f 
21 82 nr - 
 
a
 Reaction conditions:  acetone 4-1a (1.0 mL), methyl 2-oxo-4-phenylbut-3-enoate 4-2a 
(0.25 mmol), the catalyst (0.05 mmol), room temperature.  
b
 Isolated yield.  
 c
 The ee value was 
determined by chiral HPLC analysis.  
d
 The time of reaction is 18 hours.  
e
 The time of reaction is 
24 hours.  
 f




Cinchona alkaloids are privileged chiral structural scaffolds in asymmetric catalysis, 
various cinchona alkaloids were next investigated (Table 4.2). 9-amino(9-deoxy)epi-
cinchonine 38, combining with trifluoroacetic acid (TFA) afforded the products in 
excellent yields and good enantioselectivity (entry 6).  Primary amines derived from 
quinine 25, cinchonidine 61 and quinidine 62 and 63 were less effective (entries 1-4, 7-9). 
Table 4.2    Cinchona Alkaloid Derived Primary Amine Catalysts Screening for the 















1 25 - 96 -60 
2
 
25 TFA 99 -74 
3 61 - 82 -36 
4 61 TFA 70 -68 




6 38 TFA 99 76 
7 62 - 84 49 
8 62 TFA 99 66 
9 63 - 96 45 
 
a
 Reaction conditions:  acetone 4-1a (1.0 mL), methyl 2-oxo-4-phenylbut-3-enoate 4-2a 
(0.25 mmol), the catalyst (0.05 mmol), TFA (0.1 mmol), room temperature.  
b
 Isolated yield.  
 c
 
The ee value was determined by chiral HPLC analysis. 
 
4.2.2    Acid Screening for Acetone as Donor of Aldol Reaction 
Different achiral and chiral acids were screened as an additive for this model reaction 
(Table 4.3).  The camphorsulfonic acid (CSA) was also introduced in to the system.  
Compared with TFA salt of 38, (-)-CSA and (+)-CSA salt of 38 only gave a bit better 
diastereoselectivity (entries 1-3).  At the same time, many other inorganic acids were also 
compared with TFA, and from the results (entry 4-9), the TFA was confirmed to be the 
best acid for this model reaction. 
 
 




















1 TFA 1 >99% 84 
2
 
(-)-CSA 6 >99% 81 
3 (+)-CSA 6 >99% 84 
4 PhCO2H 2 >99% 69 
5 2,4-Dinitrobenzoic Acid 3 >99% 72 
6 TfOH 5 >99% 84 
7 HCO2H 3 >99% 69 
8 MeSO3H 6 56% 83 




2 >99% 73 
 
a
 Reaction conditions:  acetone 4-1a (1.0 mL), methyl 2-oxo-4-phenylbut-3-enoate 4-2a 
(0.25 mmol), the catalyst (0.05 mmol), the acid (0.1 mmol), room temperature.  
b
 Isolated yield.  
 c
 







4.2.3    Solvent Screening for Acetone as Donor of Aldol Reaction 
The effects of various common solvents were examined for the aldol reaction of 
acetone acetone 4-1a to methyl 2-oxo-4-phenylbut-3-enoate 4-2a, and the results are 
summarized in Table 4.4.  Most notably, when the model reaction was performed in neat 
acetone, complete conversion was achieved in a much shorter time and high 
enantioselectivity was obtained (entry 1).   


















1 Neat 1 99 84 
2
 
Hexane 2 >99 82 
3 Toluene 6 >99 79 
4 DCM 6 99 79 
5 CHCl3 6 99 65 
6 THF 5 >99 78 




8 CH3CN 6 99 61 
9 MeOH 3 >99 61 
10 EtOH 3 >99 58 
11 DMF 2 >99 43 
12 H2O 6 79 50 
 
a
 Reaction conditions:  acetone 4-1a (1.0 mL), methyl 2-oxo-4-phenylbut-3-enoate 4-2a 
(0.25 mmol), the catalyst (0.05 mmol), TFA (0.1 mmol), the solvent (1.0 mL), room temperature.  
b
 Isolated yield.  
 c
 The ee value was determined by chiral HPLC analysis. 
 
4.2.4    Reaction Temperature Screening for Acetone as Donor of Aldol Reaction 
After identification of 38 combined with TFA as the best catalyst system, the 
reaction temperature was next screened for the model reaction (Table 4.5).  The aldol 
adduct was obtained in 76% yield and 99% ee when the temperature was decreased to -20 
o
C (entry 3).   
























1 rt 1 99 84 
2
 
 -10 24 95 81 
3 -20 24 76 99 
4 -30 24 82 84 
5 -50 48 41 77 
 
a
 Reaction conditions:  acetone 4-1a (1.0 mL), methyl 2-oxo-4-phenylbut-3-enoate 4-2a 
(0.25 mmol), the catalyst (0.05 mmol), TFA (0.1 mmol).  
b
 Isolated yield.  
 c
 The ee value was 
determined by chiral HPLC analysis. 
 
4.2.5    Reaction Scope for Acetone as Donor of Aldol Reaction 
To establish the reaction scope, a number of -unsaturated -keto esters were 
employed as acceptors, and the results are summarized in Table 4.6.  Reactions are 
applicable to various -aryl-substituted -unsaturated -keto esters (entries 3-10).  
Different ketones were also employed for the aldol reactions, however, the results were 
not so exciting (entries 11 and 12). 



























1 73 82 
3 
 
1 42 80 
4 
 
1 44 82 
5 
 
2 trace - 
6 
 










2 79 94 
9 
 
2 trace - 
10 
 









2 trace - 
 
a
 Reaction conditions:  ketone (1.0 mL), unsaturated -keto ester (0.25 mmol), the 
catalyst (0.05 mmol), TFA (0.1 mmol).  
b
 Isolated yield.  
 c
 The ee value was determined by chiral 
HPLC analysis. 
 
4.2.6    Catalyst and Acid Screening for Hydroxyacetone as Donor of Aldol 
Reaction 
The past few years have seen remarkable progress in the primary amine-based 
enamine catalysis.
121,164,250,254,255,291,366
  In this context, our group has keen interests in 






  Therefore, we chose the direct aldol reaction 
between 1-(benzyloxy)propan-2-one 4-4a
368
 and methyl 2-oxo-4-phenylbut-3-enoate 4-
2a as a model reaction, and the catalytic effects of various primary amine catalysts were 
examined, and the results are summarized in Table 4.7.  Different amino acids, L-serine-
derived 53, L-threonine-derived 54, and diamine-based 64, were found to be effective, 
affording the desired products in moderate yields, low enantioselectivities and poor 
diastereoselectivity (entries 1-3).  Cinchona alkaloids are privileged chiral structural 
scaffolds in asymmetric catalysis; various cinchona alkaloids were next investigated.  9-
amino(9-deoxy)epi-cinchonine 38, combining with trifluoroacetic acid (TFA) afforded 
the products in excellent yields and high enantioselectivity, although only 2:1 
diastereoselectivity was observed (entry 5). The camphorsulfonic acid (CSA) was also 
introduced into the system. Compared to TFA salt of 38, (-)-CSA and (+)-CSA salt of 38 
only gave a bit better diastereoselectivity (entries 6 and 7).  Therefore, whether using 
chiral acid as the additive in the reaction or not should be further investigated.  Primary 
amines derived from quinine 25, cinchonidine 61 and quinidine 62 were less effective 
(entries 8-10), diamine-based cinchonidine derived catalyst 65 was not as effective as the 
simple cinchonidine derived primary amine catalyst 61 (entry 4). Catalyst 38 was chosen 
as the catalyst for further reactions. 
Table 4.7    Screening of Organic catalysts for the Aldol Reaction of 1-
























1 53 none 72  1:1 -5/-9 
2 54 none 71  1:1 33/17 
3 64 none 77  1:1 20/31 
4 65 TFA 79  1.5:1 -24/-30 
5 38 TFA 97  2:1 86/50 
6 38 (-)-CSA 97  3:1 88/64 




8 62 TFA 98  2.5:1 66/68 
9 61 TFA 96  2:1 -57/ -52 
10 25 TFA 96  2:1 -17/-50 
 
a
 Reaction conditions:  1-(benzyloxy)propan-2-one 4-4a (0.1 mmol), methyl 2-oxo-4-
phenylbut-3-enoate 4-2a (0.12 mmol), the catalyst (0.02 mmol), the acid (0.04 mmol), THF (0.2 
mL), room temperature.  
b
 Isolated yield.  
 c
 Determined by 
1
H NMR analysis of the crude 
reaction mixture.   
d
 The ee value was determined by chiral HPLC analysis. 
 
4.2.7    Reaction Scope for Hydroxyacetone as Donor of Aldol Reaction 
4.2.7.1    -Unsaturated -Keto Esters and Hydroxyacetone Screening 
The influence of ester moieties of different -unsaturated -keto esters and 
different protected groups of hydroxyacetone on the reactions were next examined (Table 
4.8).  Ethyl 2-oxo-4-phenylbut-3-enoate 4-2b offered improved diastereoselectivity and 
enantioselectivity, however, the chemical yield slightly dropped (entry 3).  tert-Butyl 2-
oxo-4-phenylbut-3-enoate 4-2c resulted in better diastereoselectivity with worse 
reactivity and enantioselectivity (entry 5).  Because of the steric hindrance, the aldol 
reactions could not proceed well when using iso-propyl 2-oxo-4-phenylbut-3-enoate 4-2d 
and 2-naphthyl 2-oxo-4-phenylbut-3-enoate 4-2e as electrophiles (entries 15 and 16).  




Based on the results (entries 3-6), we found that chiral acid (-)-CSA is no better than TFA.  
Thus, the TFA salt of 38 was regarded as the most efficient catalyst for this aldol reaction.  
1-(Naphthalen-2-ylmethoxy) propan-2-one 4-4b was proved to be a good nucleophile, 
affording the adducts 4-5d in good yield and diastereoselectivity with 91% ee (entry 7).  
To our disappointment, decrease the reaction temperature would not help to improve the 
result (entry 8).  A simple solvent screening revealed that THF was the best solvent for 
this aldol reaction (entries 7, 9-11). When CHCl3 was utilized as solvent, more anti 4-5d 
could be obtained (entry 11).  In contrast to 4-4b, 1-(benzhydryloxy)propan-2-one 4-4c 
was unsuitable for the this reaction, affording the adduct with low enantioselectivity 
(entry 12).  Too bulky protected groups turned out to be completely ineffective due to the 
steric hindrance, and almost no desired product was obtained (entries 13 and 14).  































Bn/Me 4-5a 1 97  3:1 88/64 
3 Bn/Et 4-5b 1 80  3:1 95/69 
4
e 
Bn/Et 4-5b 1 80  3:1 68/64 
5 Bn/tBu 4-5c 2 57  5:1 64/- 
6
e 

























4-5d 2 <20  3:1 32/66 
12 (Ph)2CH/Et 4-5e 2 88  2:1 44/87 












4-5i 2 <20  - - 
 
a
 Reaction conditions: 4-4 (0.1 mmol), 4-2 (0.12 mmol), 38 (0.02 mmol), TFA (0.04 mmol), 
THF (0.2 mL), room temperature.  
b
 Isolated yield. 
 c
 Determined by 
1
H NMR analysis of the 
crude reaction mixture.  
d
 The ee value was determined by chiral HPLC analysis. 
e
 (-)-CSA (0.04 






 CHCl3 (0.2 mL).  
h
MeOH (0.2 mL).  
i 
DMF (0.2 mL). 
 
4.2.7.2    -Unsaturated -Keto Esters Screening 
To establish the reaction scope, a number of -unsaturated -keto esters were 
employed as acceptors, and the results are summarized in Table 4.9.  Reactions are 
applicable to various -aryl-substituted -unsaturated -keto esters, and aldol products 
were obtained with very high enantioselectivities and moderate diastereoselectivities 
(entries 1-9).  Acceptors containing heterocyclic ring, such as thiophene and pyridine, 
also worked excellently for the aldol reactions, affording the desired products in great 




acceptors with aliphatic substituents on  position were totally ineffective, affording no 
desired adducts (entries 13 and 14). 
Table 4.9    Aldol Reaction of 1-(Naphthalen-2-ylmethoxy)propan-2-one 4-4b to 





















1 Ph 4-5d 81  4:1 91 
2
 
4-NO2C6H4 4-5j 86  3:1 99 
3 4-ClC6H4 4-5k 82  3.5:1 99 
4
 
4-OMeC6H4 4-5l 93  2:1 78 
5 3-OMeC6H4 4-5m 81  3:1 99 
6
 
3-BrC6H4 4-5n 87  3:1 94 
7 3-MeC6H4 4-5o 81  3:1 91 






2-MeC6H4 4-5q 97  2.5:1 99 
10
 
3-thiophenyl 4-5r 90  7:1 91 
11
 
2-thiophenyl 4-5s 92  3:1 88 
12 3-pyridinyl 4-5t 95  3:1 85 
13 iBu 4-5u nr  - - 
14 hexanyl 4-5v nr  - - 
 
a
 Reaction conditions: 4-4b (0.1 mmol), 4-2 (0.12 mmol), 38 (0.02 mmol), TFA (0.04 mmol), 
THF (0.2 mL), room temperature.  
b
 Isolated yield.  
 c
 Determined by 
1
H NMR analysis of the 
crude reaction mixture.  
d
 The ee value of the major diastereomer was determined by chiral HPLC 
analysis. 
 
4.2.7.3    X-Ray Structure of Aldol Adduct 
The absolute configuration of the tertiary alcohol 4-5 was assigned by X-ray 
structural analysis of 4-5n to be 2R,3R-configuration, that was based on a 38-catalyzed 
aldol reaction (Scheme 4.2). 






4.3    Synthesis Of 2-Substituted Glycerol Derivative 
The adducts obtained from the catalytic enantioselective aldol reaction of protected 
hydroxyacetone to -unsaturated -keto esters are rich in functionality, and ready to be 
converted into useful chiral building blocks (Scheme 4.3).  The Pd/C reduction of 4-5n 
afforded chiral -hydroxyl carbonyl compound 4-6, which containing one tertiary alcohol 
as well as one secondary alcohol.  Chiral glycerol derivative was accessed by treating 4-6 
with LiAlH4 at 0 
o
C to effect a global reduction and give the 2-substituted glycerol 
derivative 4-7 (two diastereomers mixture, 1:1). 





4.4    Conclusion 
In conclusion, we have developed the first highly enantioselective aldol reaction of 
protected hydroxyacetone to -unsaturated -keto ester catalyzed by 9-amino(9-
deoxy)epi-cinchonine and trifluoroacetic acid.  The synthetic route reported provided 
efficient access to chiral tertiary alcohol skeletons and glycerol derivatives.  Extension of 
this method to other catalytic asymmetric reactions is under investigation in our 
laboratory. 
 
4.5    Experimental Section 
4.5.1    General Information 





C NMR spectra were recorded on a Bruker ACF300 or an AMX500 
(500 MHz) spectrometer. Chemical shifts were reported in parts per million (ppm), and 
the residual solvent peak was used as an internal reference: proton (chloroform δ 7.26), 
carbon (chloroform δ 77.0). Multiplicity was indicated as follows: s (singlet), d (doublet), 
t (triplet), q (quartet), m (multiplet), dd (doublet of doublet), br s (broad singlet). 
Coupling constants were reported in Hertz (Hz). Low-resolution mass spectra were 
obtained on a Finnigan/MAT LCQ spectrometer in ESI mode, and a Finnigan/MAT 
95XL-T mass spectrometer in FAB mode. All high-resolution mass spectra were obtained 
on a Finnigan/MAT 95XL-T spectrometer. For thin-layer chromatography (TLC), Merck 




a UV light at 254 nm. Further visualization was achieved by staining with iodine, or ceric 
ammonium molybdate followed by heating on a hot plate. Flash chromatographic 
separations were performed on Merck 60 (0.040 - 0.063 mm) mesh silica gel. The 
enantiomeric excesses of products were determined by chiral-phase HPLC analysis.    
1-(Benzyloxy)propan-2-one was purchased from Sigma-Aldrich.  Other protected 
hydroxyacetone
369
 and -unsaturated -keto esters370 were prepared as reported in the 
literature. 
 
4.5.2    Representative Procedure: Aldol Reaction of Acetone to Ethyl 2-oxo-4-
phenylbut-3-enoate 
 
Acetone (0.5 mL) was added to a mixture of 9-amino(9-deoxy)epi-cinchonine 38 
(5.8 mg, 0.02 mmol),  TFA (3.0 μL, 0.04 mmol) and ethyl 2-oxo-4-phenylbut-3-enoate 
(22.4 mg, 0.12 mmol) in a sample vial at room temperature. The vial was then sealed and 
the reaction mixture was stirred at -20 
o
C for 1 day.  Then the reaction mixture was 
concentrated in vacuo and purified by flash column chromatography (ethyl 
acetate/hexanes = 1:10 to 1:3) afforded the desired product as a yellow oil ( yield 76%). 






4.5.3    Representative Procedure: Aldol Reaction of 1-(Naphthalen-2-
ylmethoxy)propan-2-one to Ethyl 2-oxo-4-phenylbut-3-enoate 
 
1-(Naphthalen-2-ylmethoxy)propan-2-one (21.4 mg, 0.1 mmol) was added to a 
mixture of 9-amino(9-deoxy)epi-cinchonine 38 (5.8 mg, 0.02 mmol),  TFA (3.0 μL, 0.04 
mmol) and ethyl 2-oxo-4-phenylbut-3-enoate (22.4 mg, 0.12 mmol) in THF (0.2 mL) in a 
sample vial at room temperature. The vial was then sealed and the reaction mixture was 
stirred at room temperature for 2 days.  Then the solvent was concentrated in vacuo and 
purified by flash column chromatography (ethyl acetate/hexanes = 1:10 to 1:3) afforded 
the desired product as a yellow oil (yield 81%). The enantiometric excess of product was 
determined by chiral HPLC analysis. 
 





Following the representative procedure illustrated in section B, the aldol reaction of 
1-(naphthalen-2-ylmethoxy)propan-2-one to ethyl 4-(3-bromophenyl)-2-oxobut-3-enoate 
was performed to give the adduct 3n, which was conducted Pd/C reduction to yield the 
(2R,3R)-ethyl 2-(3-bromophenethyl)-2,3-dihydroxy-4-oxopentanoate 4-6.  Treating 4-6 
with LiAlH4 at 0 
o
C to give the 2-substituted glycerol derivatives 4-7  
  
(2R,3R)-ethyl 2-(3-bromophenethyl)-2,3-dihydroxy-4-oxopentanoate 4-6 
The (2R,3R)-ethyl 2-(3-bromostyryl)-2-hydroxy-3-(naphthalen-2-ylmethoxy)-4-
oxopentanoate 3n (74.5 mg, 0.15 mmol), 10% Pd/C ( 32.5 mg, 0.03mmol) and methanol 
(2 mL) were combined and the reaction vessel was evacuated and back-filled with 
hydrogen (1 atm).   The reaction mixture was stirred under hydrogen and traced by TLC.  
Then the mixture was concentrated and purified by flash column chromatography (ethyl 
acetate/hexanes = 1:3) to afford the desired product 4-6 as a colorless oil (34.0 mg, 63%). 
 
(2S,3S)-2-(3-bromophenethyl)pentane-1,2,3,4-tetraol 4-7 
To LAH (7.6 mg, 0.2 mmol) in THF (1.0 mL) was added a solution of the (2R,3R)-
ethyl 2-(3-bromophenethyl)-2,3-dihydroxy-4-oxopentanoate 4 (27.0 mg, 0.075 mmol) in 
THF (1.0 mL) at 0 
o
C under nitrogen.  When the addition was completed, the cooling 
bath was removed and the mixture was stirred at room temperature.  Using TLC traced 
reaction.  After the reaction completing, the mixture was cooled to 0 
o




was carefully quenched with water, 15 % aqueous sodium hydroxide and water.  After 
being stirred for 30 minutes, the reaction was extracted with ethyl acetate (3 X 3.0 mL).  
The combined organic extracts were washed with brine and dried (MgSO4).  After 
concentration, the residue was purified by flash column chromatography (ethyl acetate) to 
afford the desired product 5 as colorless oil (17.0 mg, 71%). 
 
4.5.5    Analytical Data and HPLC Chromatogram of Aldol Adducts 
The detailed analytical data of aldol adduct 4-3 could refer to known literature
364
. 
(S)-methyl 2-hydroxy-4-oxo-2-styrylpentanoate 4-3a 
 
was prepared according to the general procedure.  The product was obtained in 76% 
yield, white solid.  The ee value was 99%; 
1
H NMR (500 MHz, CDCl3) δ 7.38 (d, J = 7.5 
Hz, 2H), 7.31 (q, J = 7.5 Hz, 2H), 7.27-7.24 (m, 1H), 6.86 (d, J = 16.0 Hz, 1H), 6.16 (d, J 
= 16.0 Hz, 1H), 3.80 (s, 3H), 3.26 (d, J = 17.5 Hz, 1H), 2.93 (d, J = 17.5 Hz, 1H), 2.19 (s, 
3H). 
 





was prepared according to the general procedure.  The product was obtained in 73% 
yield, colorless oil.  The ee value was 82%;  
1
H-NMR (500 MHz, CDCl3): δ7.37 (d, J = 
7.5 Hz, 2H), 7.31 (t, J = 7.3 Hz, 2H), 7.26-7.23 (m, 1H), 6.86 (d, J = 16.0 Hz, 1H), 6.17 
(d, J = 16.0 Hz, 1H), 4.31-4.22 (m, 2H), 4.01 (br s, 1H), 3.25 (d, J = 17.0 Hz, 1H), 2.92 
(d, J = 17.0 Hz, 1H), 2.19 (s, 3H), 1.30 (t, J = 7.3 Hz, 3H). 
 
(S)-methyl 2-(4-nitrostyryl)-2-hydroxy-4-oxopentanoate 4-3c 
 
was prepared according to the general procedure.  The product was obtained in 42% 
yield, colorless oil.  The ee value was 82%;  
1
H-NMR (500 MHz, CDCl3): δ8.16 (d, J = 
9.0 Hz, 2H), 7.50 (d, J = 8.5 Hz, 2H), 6.95 (d, J = 16.0 Hz, 1H), 6.34 (d, J = 15.5 Hz, 1H), 
4.09 (br s, 1H), 3.81 (s, 3H), 3.27 (d, J = 17.5 Hz, 1H), 2.92 (d, J = 17.5 Hz, 1H), 2.20 (s, 
3H). 
 





was prepared according to the general procedure.  The product was obtained in 44% 
yield, white solid.  The ee value was 82%;  
1
H-NMR (500 MHz, CDCl3): δ7.30-7.28 (m, 
4H), 6.81 (d, J = 15.5 Hz, 1H), 6.14 (d, J = 16.0 Hz, 1H), 4.00 (br s, 1H), 3.81 (s, 3H), 
3.24 (d, J = 17.5 Hz, 1H), 2.90 (d, J = 17.0 Hz, 1H), 2.18 (s, 3H). 
 
(S)-methyl 2-(3-methoxystyryl)-2-hydroxy-4-oxopentanoate 4-3f 
 
was prepared according to the general procedure.  The product was obtained in 32% 
yield, colorless oil.  The ee value was 81%;  
1
H-NMR (500 MHz, CDCl3): δ7.23 (t, J = 
8.0 Hz, 1H), 6.97 (d, J = 7.5 Hz, 1H), 6.90 (t, J = 2.0 Hz, 1H), 6.83 (d, J = 16.0 Hz, 1H), 
6.82-6.80 (m, 1H), 6.16 (d, J = 15.5 Hz, 1H), 3.82 (s, 3H), 3.80 (s, 3H), 3.25 (d, J = 17.5 
Hz, 1H), 2.92 (d, J = 17.5 Hz, 1H), 2.19 (s, 3H). 
 
 





was prepared according to the general procedure.  The product was obtained in 60% 
yield, colorless oil.  The ee value was 81%;  
1
H-NMR (500 MHz, CDCl3): δ7.36 (d, J = 
2.0 Hz, 1H), 7.24-7.20 (m, 2H), 6.81 (d, J = 16.0 Hz, 1H), 6.18 (d, J = 16.0 Hz, 1H), 4.01 
(br s, 1H), 3.82 (s, 3H), 3.24 (d, J = 17.5 Hz, 1H), 2.90 (d, J = 17.5 Hz, 1H), 2.19 (s, 3H). 
 
(S)-methyl 2-(3,5-methoxystyryl)-2-hydroxy-4-oxopentanoate 4-3h 
 
was prepared according to the general procedure.  The product was obtained in 79% 
yield, colorless oil.  The ee value was 94%;  
1
H-NMR (500 MHz, CDCl3):δ7.23 (t, J = 
8.0 Hz, 1H), 6.97 (d, J = 7.5 Hz, 1H), 6.83 (d, J = 16.0 Hz, 1H), 6.82-6.80 (m, 1H), 6.16 
(d, J = 15.5 Hz, 1H), 3.82 (s, 3H), 3.80 (s, 6H), 3.25 (d, J = 17.5 Hz, 1H), 2.92 (d, J = 







was prepared as reported in literature
1
 and purified as colorless oil.  
1
H NMR (300 
MHz, CDCl3) δ2.19 (s, 3H), 4.12 (s, 2H), 4.78 (s, 2H), 7.51-7.55 (m, 3H), 7.83-7.90 (m, 
4H); 
13
C NMR (75 MHz, CDCl3,) δ26.4, 73.3, 75.1, 125.7, 126.1, 126.2, 126.8, 127.7, 
127.9, 128.4, 133.1, 133.2, 134.6, 206.5; HRMS (ESI) m/z calcd for C14H14O2 [M+Na]
+
 
237.0891, found 237.0896. 
 
(2R,3R)-methyl 3-(benzyloxy)-2-hydroxy-4-oxo-2-styrylpentanoate 4-5a 
 
was purified as a 2:1 diastereomeric mixture and isolated as a yellow oil following 
the typical procedure; The ee value was 86%, 50%; syn isomer: tR (major) = 33.04 min, tR 
(minor) = 42.12 min; anti isomer: tR (minor) = 45.43 min, tR (major) = 68.56 min 
(Chiralcel AD-H, λ = 254 nm, 5% iPrOH/hexanes, flow rate = 0.8 mL/min); 1H NMR 
(500 MHz, CDCl3, mixture of diastereomers) δ2.25 (s, 3H), 2.29 (s, 3H), 3.70, (s, 6H), 
3.86 (s, 2H), 4.10 (s, 1H), 4.11 (s, 1H), 4.23-4.78 (m, 4H, CH2 for both diastereomers), 
6.20 (d, J = 15.7 Hz, 1H), 6.25 (d, J = 15.7 Hz, 1H), 6.87 (d, J = 15.7 Hz, 1H), 6.96 (d, J 
= 15.7 Hz, 1H), 7.28-7.41 (m, 20H); 
13




diastereomers) δ28.1, 53.4, 79.7, 87.4, 123.9, 126.1, 126.7, 126.9, 127.9, 128.1, 128.3, 
128.5, 131.7, 131.9, 135.9, 136.3, 172.6, 207.7; HRMS (ESI) m/z calcd for C21H22O5 
[M+Na]
+
 377.1359, found 377.1359. 
 
 (2R,3R)-ethyl 3-(benzyloxy)-2-hydroxy-4-oxo-2-styrylpentanoate 4-5b 
 
was purified as a 5:1 diastereomeric mixture and isolated as a yellow oil following 
the typical procedure; The ee value was 91%; syn isomer: tR (major) = 34.50 min, tR 
(minor) = 41.02 min (Chiralcel AD-H, λ = 254 nm, 3% iPrOH/hexanes, flow rate = 0.8 
mL/min); 
1
H NMR (500 MHz, CDCl3) δ1.21 (t, J = 7.2 Hz, 3H), 2.25 (s, 3H), 3.88 (s, 
1H), 4.10-4.27 (m, 3H), 4.43 (d, J = 11.3 Hz, 1H), 4.69 (d, J = 11.3 Hz, 1H), 6.26 (d, J = 
15.7 Hz, 1H), 6.88 (d, J = 15.8 Hz, 1H), 7.28-7.41 (m, 10H); 
13
C NMR (125 MHz, CDCl3) 
δ14.0, 26.4, 62.8, 73.3, 79.2, 87.7, 124.1, 126.9, 127.9, 128.0, 128.2, 128.5, 128.6, 131.6, 











was purified as a 5:1 diastereomeric mixture and isolated as a yellow oil following 
the typical procedure; The ee value was 55%; syn isomer: tR (major) = 37.71 min, tR 
(minor) = 41.74 min (Chiralcel AD-H, λ = 254 nm, 3% iPrOH/hexanes, flow rate = 0.8 
mL/min); 
1
H NMR (500 MHz, CDCl3) δ1.46 (s, 9H), 2.22, 2.26 (2s, 3H, CH3 for two 
diastereomers), 3.88 (s, 1H), 4.20 (s, 1H), 4.23-4.62 (m, 2H), 6.25 (d, J = 15.8 Hz, 1H), 
6.86 (d, J = 15.7 Hz, 1H), 7.26-7.46 (m, 10H); 
13
C NMR (125 MHz, CDCl3) δ26.4, 27.9, 
73.3, 79.1, 83.9, 88.2, 124.7, 126.9, 127.9, 128.2, 128.3, 128.5, 129.0, 131.4, 136.2, 137.1, 
171.1, 208.4; HRMS (ESI) m/z calcd for C24H28O5 [M+Na]
+





was purified as a 4:1 diastereomeric mixture and isolated as a yellow oil following 
the typical procedure; The ee value was 91%; syn isomer: tR (major) = 23.75 min, tR 
(minor) = 25.75 min (Chiralcel AD-H, λ = 254 nm, 10% iPrOH/hexanes, flow rate = 0.8 
mL/min); 
1




3.91 (s, 1H), 4.01-4.07 (m, 1H), 4.17-4.23 (m, 1H), 4.30 (s, 1H), 4.57 (d, J = 11.3 Hz, 
1H), 4.87 (d, J = 11.3 Hz, 1H), 6.26 (d, J = 15.7 Hz, 1H), 6.88 (d, J = 15.7 Hz, 1H), 7.26-
7.88 (m, 12H); 
13
C NMR (125 MHz, CDCl3, syn isomer) δ13.9, 26.4, 62.8, 73.4, 79.2, 
87.5, 124.1,125.7, 126.1, 126.2, 126.4, 126.8, 126.9, 127.3, 127.7, 127.9, 128.4, 128.5, 
131.6, 133.1, 134.6, 136.0, 172.1, 206.6
25
D = 39.9 (c = 1.00 in CHCl3); HRMS (ESI) 
m/z calcd for C26H26O5 [M+Na]
+
 441.1672, found 441.1686. 
 
(2R,3R)-ethyl 3-(2,2-diphenylethoxy)-2-hydroxy-4-oxo-2-styrylpentanoate 4-5e 
 
was purified as a 2:1 diastereomeric mixture and isolated as a yellow oil following 
the typical procedure; The ee value was 44%, 87%; syn isomer: tR (major) = 11.05 min, tR 
(minor) = 14.07 min, anti isomer: tR (minor) = 27.01 min, tR (major) = 33.94 min 
(Chiralcel AD-H, λ = 254 nm, 10% iPrOH/hexanes, flow rate = 1.0 mL/min); 1H NMR 
(500 MHz, CDCl3, mixture of diastereomers) δ0.92 (t, J = 6.9 Hz, 3H), 1.11 (t, J = 7.4 Hz, 
3H), 2.25 (s, 6H), 4.02 (s, 1H), 4.10 (s, 1H), 4.16-4.32 (m, 8H), 6.15 (d, J = 16.4 Hz, 1H), 
6.23 (d, J = 15.7 Hz, 1H), 6.90 (d, J = 15.7 Hz, 1H), 6.94 (d, J = 15.7 Hz, 1H), 7.28-
7.48(m, 30H); 
13
C NMR (125 MHz, CDCl3, mixture of diastereomers) δ14.1, 26.8, 62.5, 




134.0, 141.1, 142.1, 148.5, 172.2, 207.0; HRMS (ESI) m/z calcd for C28H28O5 [M+Na]
+
 





was purified as a 3:1 diastereomeric mixture and isolated as a yellow oil following 
the typical procedure; The ee value was 99%; syn isomer: tR (major) = 38.19 min, tR 
(minor) = 49.60 min (Chiralcel AD-H, λ = 254 nm, 5% iPrOH/hexanes, flow rate = 0.8 
mL/min); 
1
H NMR (500 MHz, CDCl3, syn isomer) δ1.09 (t, J = 6.9 Hz, 3H), 2.29 (s, 3H), 
3.96 (s, 1H), 4.04-4.25 (m, 2H), 4.27 (s, 1H), 4.58 (d, J = 12.0 Hz, 1H), 4.88 (d, J = 12.0 
Hz, 1H), 6.43 (d, J = 15.8 Hz, 1H), 6.92 (d, J = 15.8 Hz, 1H), 7.37-8.18 (m, 11H); 
13
C 
NMR (125 MHz, CDCl3, syn isomer) δ13.9, 28.0, 63.2, 73.7, 79.4, 87.4, 123.9, 125.9, 
126.4, 126.5, 127.3, 127.4, 127.5, 127.7, 127.9, 128.5, 129.0, 129.5, 129.8, 133.1, 133.2, 
133.4, 142.4, 147.2, 171.5, 208.3
25
D = 37.4 (c = 2.00 in CHCl3); HRMS (ESI) m/z 
calcd for C26H25NO7 [M+Na]
+








was purified as a 3.5:1 diastereomeric mixture and isolated as a yellow oil following 
the typical procedure; The ee value was 99%; syn isomer: tR (minor) = 38.67 min, tR 
(major) = 41.08 min (Chiralcel AD-H, λ = 254 nm, 5% iPrOH/hexanes, flow rate = 0.8 
mL/min); 
1
H NMR (500 MHz, CDCl3, syn isomer) δ1.09 (t, J = 7.2 Hz, 3H), 2.28 (s, 3H), 
3.92 (s, 1H), 4.01-4.08 (m, 1H), 4.17-4.24 (m, 1H), 4.27 (s, 1H), 4.57 (d, J = 11.9 Hz, 
1H), 4.87 (d, J = 12.0 Hz, 1H), 6.23 (d, J = 15.7 Hz, 1H), 6.82 (d, J = 15.8 Hz, 1H), 7.27-
7.89 (m, 11H); 
13
C NMR (125 MHz, CDCl3, syn isomer) δ13.9, 28.1, 62.9, 73.4, 79.2, 
87.5, 124.8, 125.7, 125.9, 126.1, 126.3, 126.4, 126.8, 127.3, 127.7, 127.9, 128.1, 128.4, 
128.7, 130.3, 133.1, 133.7, 134.6, 171.9, 206.6
25
D = 34.6 (c = 2.00 in CHCl3); 
HRMS (ESI) m/z calcd for C26H25ClO5 [M+Na]
+








was purified as a 2:1 diastereomeric mixture and isolated as a yellow oil following 
the typical procedure; The ee value was 78%; syn isomer: tR (minor) = 99.65 min, tR 
(major) = 107.20 min (Chiralcel AD-H, λ = 254 nm, 5% iPrOH/hexanes, flow rate = 0.8 
mL/min); 
1
H NMR (500 MHz, CDCl3, syn isomer) δ1.08 (t, J = 7.2 Hz, 3H), 2.27 (s, 3H), 
3.82 (s, 3H), 3.87 (s, 1H), 4.02-4.21 (m, 2H), 4.28 (s, 1H), 4.56 (d, J = 11.3 Hz, 1H), 4.88 
(d, J = 11.3 Hz, 1H), 6.11 (d, J = 15.7 Hz, 1H), 6.80-7.88 (m, 12H); 
13
C NMR (125 MHz, 
CDCl3, syn isomer) δ13.9, 28.2, 55.3, 62.8, 73.4, 79.2, 87.6, 113.9, 121.8, 125.9, 126.3, 
126.4, 127.3, 127.7, 127.9, 128.1, 128.4, 128.7, 131.0, 133.1, 133.8, 159.6, 172.3, 207.9; 
25
D = 7.4 (c = 1.00 in CHCl3); HRMS (ESI) m/z calcd for C27H28O6 [M+Na]
+
 





was purified as a 3:1 diastereomeric mixture and isolated as a yellow oil following 




(major) = 21.31 min (Chiralcel AD-H, λ = 254 nm, 10% iPrOH/hexanes, flow rate = 1.0 
mL/min); 
1
H NMR (300 MHz, CDCl3, syn isomer) δ1.11 (t, J = 7.2 Hz, 3H), 2.30 (s, 3H), 
3.82 (s, 3H), 3.93 (s, 1H), 4.03-4.25 (m, 2H), 4.31 (s, 1H), 4.58 (d, J = 11.8 Hz, 1H), 4.89 
(d, J = 11.8 Hz, 1H), 6.28 (d, J = 15.7 Hz, 1H), 6.82-7.89 (m, 12H); 
13
C NMR (75 MHz, 
CDCl3, syn isomer) δ13.8, 28.0, 55.1, 62.8, 73.3, 79.1, 87.5, 112.1, 113.7, 119.4, 124.4, 
125.8, 126.2, 126.3, 127.6, 127.8, 128.3, 129.4, 131.5, 133.0, 133.1, 133.7, 137.3, 159.7, 
172.0, 207.6
25
D = 70.8 (c = 4.00 in CHCl3); HRMS (ESI) m/z calcd for C27H28O6 
[M+Na]
+





was purified as a 3:1 diastereomeric mixture and isolated as a white crystal following 
the typical procedure; The ee value was 94%; syn isomer: tR (minor) = 35.71 min, tR 
(major) = 38.34 min (Chiralcel AD-H, λ = 254 nm, 5% iPrOH/hexanes, flow rate = 0.8 
mL/min); 
1
H NMR (300 MHz, CDCl3, syn isomer) δ1.10 (t, J = 7.3 Hz, 3H), 2.30 (s, 3H), 
3.82 (s, 3H), 3.99 (s, 1H), 4.04-4.25 (m, 2H), 4.30 (s, 1H), 4.58 (d, J = 11.8 Hz, 1H), 4.88 
(d, J = 11.8 Hz, 1H), 6.30 (d, J = 15.6 Hz, 1H), 6.83 (d, J = 15.7 Hz, 1H), 7.15-7.90 (m, 
10H); 
13




125.6, 125.8, 126.0, 126.2, 126.3, 126.7, 127.2, 127.6, 127.8, 128.3, 129.5, 130.8, 133.0, 
133.6, 134.5, 138.0, 171.8, 207.9
25
D = 25.3 (c = 1.00 in CHCl3); HRMS (ESI) m/z 
calcd for C26H25BrO5 [M+Na]
+





was purified as a 3:1 diastereomeric mixture and isolated as a white crystal following 
the typical procedure; The ee value was 91%; syn isomer: tR (minor) = 31.29 min, tR 
(major) = 34.09 min (Chiralcel AD-H, λ = 254 nm, 5% iPrOH/hexanes, flow rate = 0.8 
mL/min); 
1
H NMR (300 MHz, CDCl3, syn isomer) δ1.11 (t, J = 7.0 Hz, 3H), 2.30 (s, 3H), 
2.36 (s, 3H), 3.92 (s, 1H), 4.03-4.27 (m, 2H), 4.31 (s, 1H), 4.58 (d, J = 11.8 Hz, 1H), 4.89 
(d, J = 11.8 Hz, 1H), 6.27 (d, J = 15.7 Hz, 1H), 6.87 (d, J = 15.7 Hz, 1H), 7.09-7.91 (m, 
10H); 
13
C NMR (75 MHz, CDCl3, syn isomer) δ13.8, 21.2, 28.0, 62.7, 73.3, 79.1, 87.5, 
123.8, 124.1, 125.8, 126.2, 126.3, 127.2, 127.4, 127.6, 127.9, 128.3, 128.8, 131.6, 133.0, 
133.1, 133.7, 135.8, 138.0, 172.0, 207.7
25
D = 50.6 (c = 4.00 in CHCl3); HRMS (ESI) 
m/z calcd for C27H28O5 [M+Na]
+








was purified as a 3:1 diastereomeric mixture and isolated as a white crystal following 
the typical procedure; The ee value was 90%; syn isomer: tR (minor) = 51.45 min, tR 
(major) = 55.43 min (Chiralcel AD-H, λ = 254 nm, 5% iPrOH/hexanes, flow rate = 0.5 
mL/min); 
1
H NMR (500 MHz, CDCl3, syn isomer) δ1.09 (t, J = 7.2 Hz, 3H), 2.29 (s, 3H), 
3.93 (s, 1H), 4.03-4.23 (m, 2H), 4.30 (s, 1H), 4.58 (d, J = 11.3 Hz, 1H), 4.87 (d, J = 11.3 
Hz, 1H), 6.38 (d, J = 15.7 Hz, 1H), 7.00-7.86 (m, 12H); 
13
C NMR (125 MHz, CDCl3, syn 
isomer) δ13.8, 28.1, 62.9, 73.5, 79.3, 87.6, 115.6, 115.8, 124.0, 124.4, 125.9, 126.3, 
126.4, 126.9, 127.3, 127.7, 127.9, 128.2, 128.4, 129.4, 133.2, 133.7, 159.4, 161.4, 171.9, 
207.9
25
D = 102.8 (c = 4.00 in CHCl3); HRMS (ESI) m/z calcd for C26H25FO5 
[M+Na]
+








was purified as a 2.5:1 diastereomeric mixture and isolated as a white crystal 
following the typical procedure; The ee value was 99%; syn isomer: tR (minor) = 29.90 
min, tR (major) = 32.21 min (Chiralcel AD-H, λ = 254 nm, 5% iPrOH/hexanes, flow rate 
= 0.8 mL/min); 
1
H NMR (500 MHz, CDCl3, syn isomer) δ1.09 (t, J = 7.0 Hz, 3H), 2.30 (s, 
3H), 2.34 (s, 3H), 3.93 (s, 1H), 4.02-4.23 (m, 2H), 4.30 (s, 1H), 4.57 (d, J = 11.3 Hz, 1H), 
4.87 (d, J = 11.9 Hz, 1H), 6.15 (d, J = 15.1 Hz, 1H), 7.09-7.86 (m, 12H); 
13
C NMR (125 
MHz, CDCl3, syn isomer) δ13.9, 19.7, 26.4, 62.8, 73.4, 79.3, 87.7, 125.7, 126.1, 126.2, 
126.8, 127.7, 127.9, 128.4, 129.6, 130.2, 133.1, 133.2,  134.6, 135.9, 143.0, 172.2, 206.5; 
25
D = 73.0 (c = 5.00 in CHCl3); HRMS (ESI) m/z calcd for C27H28O5 [M+Na]
+
 





was purified as a 7:1 diastereomeric mixture and isolated as a white crystal following 
the typical procedure; The ee value was 91%; syn isomer: tR (minor) = 28.77 min, tR 
(major) = 34.60 min (Chiralcel AD-H, λ = 254 nm, 20% iPrOH/hexanes, flow rate = 1.0 
mL/min); 
1
H NMR (500 MHz, CDCl3, syn isomer) δ1.34 (t, J = 7.2 Hz, 3H), 2.32 (s, 3H), 




Hz, 1H), 6.08 (d, J = 15.7 Hz, 1H), 6.97-7.86 (m, 11H); 
13
C NMR (125 MHz, CDCl3, syn 
isomer) δ14.0, 28.3, 63.0, 73.5, 79.5, 87.4, 124.1, 125.0, 125.3, 125.6, 126.1, 126.2, 
126.8, 127.4, 127.7, 128.0, 128.4, 133.1, 134.0, 141.1, 171.9, 206.4
25
D = 15.4 (c = 
1.50 in CHCl3); HRMS (ESI) m/z calcd for C24H24O5S [M+Na]
+






was purified as a 3:1 diastereomeric mixture and isolated as a white crystal following 
the typical procedure; The ee value was 88%; syn isomer: tR (major) = 22.53 min, tR 
(minor) = 24.69 min (Chiralcel AD-H, λ = 254 nm, 10% iPrOH/hexanes, flow rate = 1.0 
mL/min); 
1
H NMR (500 MHz, CDCl3, syn isomer) δ1.09 (t, J = 6.9 Hz, 3H), 2.28 (s, 3H), 
3.90 (s, 1H), 4.01-4.24 (m, 2H), 4.27 (s, 1H), 4.56 (d, J = 12.0 Hz, 1H), 4.86 (d, J = 12.0 
Hz, 1H), 6.11 (d, J = 15.7 Hz, 1H), 6.95-7.89 (m, 11H); 
13
C NMR (125 MHz, CDCl3, syn 
isomer) δ13.9, 28.2, 62.9, 73.4, 79.0, 87.4, 123.4, 124.9, 125.1, 125.9, 126.3, 126.4, 
126.9, 127.3, 127.4, 127.7, 127.9, 128.4, 133.1, 134.6, 140.9, 171.9, 207.6
25
D = 82.6 
(c = 4.50 in CHCl3); HRMS (ESI) m/z calcd for C24H24O5S [M+Na]
+








was purified as a 3:1 diastereomeric mixture and isolated as a white crystal following 
the typical procedure; The ee value was 85%; syn isomer: tR (major) = 52.98 min, tR 
(minor) = 70.28 min (Chiralcel AD-H, λ = 254 nm, 10% iPrOH/hexanes, flow rate = 1.0 
mL/min); 
1
H NMR (500 MHz, CDCl3, mixture of diastereomers) δ1.08 (t, J = 6.9 Hz, 
3H), 1.27 (t, J = 6.9 Hz, 3H), 2.29 (s, 3H), 2.33 (s, 3H), 4.04-4.33 (m, 8H), 4.57 (d, J = 
12.0 Hz, 1H), 4.73 (d, J = 12.0 Hz, 1H), 4.86 (d, J = 11.3 Hz, 1H), 4.97 (d, J = 11.3 Hz, 
1H), 6.23 (d, J = 15.7 Hz, 1H), 6.35 (d, J = 15.7 Hz, 1H), 6.87 (d, J = 16.4 Hz, 1H), 6.95 
(d, J = 15.7 Hz, 1H), 7.21-8.61 (m, 22H); 
13
C NMR (125 MHz, CDCl3, mixture of 
diastereomers) δ13.9, 28.1, 63.0, 73.6, 79.3, 87.6, 123.4, 125.9, 126.4, 126.6, 127.3, 
127.7, 127.9, 128.1, 128.4, 128.8, 131.7, 133.1, 133.4, 133.6, 148.6, 149.0, 171.7, 208.1; 
25
D = 81.0 (c = 5.00 in CHCl3); HRMS (ESI) m/z calcd for C25H26NO5 [M+H]
+
 







(2R,3R)-ethyl 2-(3-bromophenethyl)-2,3-dihydroxy-4-oxopentanoate 4-6 
 
was isolated as a colorless oil following the procedure; 
1
H NMR (300 MHz, CDCl3) 
δ1.35 (t, J = 7.1 Hz, 3H), 2.10-2.19 (m, 2H), 2.27 (s, 3H), 2.29-2.55 (m, 1H), 2.91-2.91 
(m, 1H), 3.71 (d, J = 8.7 Hz, 1H), 3.79 (s, 1H), 4.24-4.31 (m, 3H), 7.20-7.35 (m, 4H); 
13
C 
NMR (75 MHz, CDCl3, syn isomer) δ14.0, 28.4, 29.5, 37.3, 62.6, 78.8, 80.2, 126.0, 128.3, 
140.9, 174.0, 208.3
25
D = 30.2 (c = 1.00 in CHCl3); HRMS (ESI) m/z calcd for 
C15H19BrO5 [M+H]
+




was isolated as a colorless oil following the procedure; 
1
H NMR (500 MHz, CDCl3, 
1:1 mixture of diastereomers) δ1.27-1.39 (m, 5H), 1.74-2.08 (m, 3H), 262-2.87 (m, 3H), 
3.27-3.89 (m, 3H), 4.03-4.06 (2s, 1H), 7.21-7.74 (m, 4H); 
13
C NMR (125 MHz, CDCl3, 




128.4, 128.5, 142.3; HRMS (ESI) m/z calcd for C13H19BrO4 [M+H]
+
 319.0539, found 
319.0545. 
 






Table 1.  Crystal data and structure refinement for 4-5n. 
Identification code  4-5n 
Empirical formula  C26 H25 Br O5 
Formula weight  497.37 
Temperature  223(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1) 
Unit cell dimensions a = 13.1314(9) Å = 90°. 
 b = 5.8958(4) Å = 109.439(2)°. 
 c = 15.9344(11) Å  = 90°. 
Volume 1163.32(14) Å3 
Z 2 
Density (calculated) 1.420 Mg/m3 
Absorption coefficient 1.801 mm-1 
F(000) 512 
Crystal size 1.00 x 0.30 x 0.16 mm3 
Theta range for data collection 1.64 to 27.50°. 
Index ranges -14<=h<=17, -7<=k<=7, -20<=l<=19 
Reflections collected 8235 
Independent reflections 4635 [R(int) = 0.0330] 
Completeness to theta = 27.50° 99.7 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.7615 and 0.2660 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4635 / 1 / 292 
Goodness-of-fit on F2 1.061 
Final R indices [I>2sigma(I)] R1 = 0.0521, wR2 = 0.1045 




Absolute structure parameter 0.009(10) 




Table 2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters 
(Å2x 103) for 4-5n.  U(eq) is defined as one third of  the trace of the orthogonalized Uij 
tensor. 
________________________________________________________________________ 
 x y z U(eq) 
________________________________________________________________________  
Br(1) 12391(1) 4303(1) 9913(1) 52(1) 
O(1) 6389(2) 6291(5) 8053(2) 39(1) 
O(2) 4408(2) 4697(5) 6902(1) 36(1) 
O(3) 6392(3) 3225(9) 5983(2) 84(1) 
O(4) 5641(2) 4239(8) 9205(2) 61(1) 
O(5) 5154(2) 1159(5) 8348(2) 45(1) 
C(1) 10138(3) 3505(6) 9173(2) 30(1) 
C(2) 11145(3) 2583(7) 9314(2) 33(1) 
C(3) 11260(3) 451(7) 9000(3) 40(1) 
C(4) 10339(3) -739(10) 8522(2) 43(1) 
C(5) 9328(3) 169(7) 8360(3) 40(1) 
C(6) 9209(3) 2322(6) 8689(2) 29(1) 
C(7) 8161(3) 3457(7) 8494(2) 31(1) 
C(8) 7196(3) 2597(7) 8075(2) 30(1) 
C(9) 6171(3) 3946(6) 7904(2) 30(1) 
C(10) 5382(3) 3605(7) 6949(2) 34(1) 
C(11) 5867(3) 4484(13) 6272(2) 55(1) 
C(12) 5672(5) 6931(12) 6005(4) 90(2) 
C(13) 3485(3) 3689(8) 6263(3) 50(1) 
C(14) 2495(3) 5040(7) 6212(2) 38(1) 
C(15) 2324(3) 7162(8) 5785(2) 41(1) 
C(16) 1427(3) 8398(7) 5701(2) 38(1) 




C(18) -359(3) 8724(6) 5914(2) 39(1) 
C(19) -1129(3) 7810(9) 6207(3) 48(1) 
C(20) -965(4) 5714(9) 6636(3) 50(1) 
C(21) -24(3) 4565(8) 6780(2) 39(1) 
C(22) 786(3) 5431(6) 6474(2) 31(1) 
C(23) 1751(2) 4229(8) 6560(2) 36(1) 
C(24) 5609(3) 3129(7) 8564(2) 37(1) 
C(25) 4571(4) 204(8) 8908(3) 55(1) 





Table 3.   Bond lengths [Å] and angles [°] for  4-5n. 
________________________________  
Br(1)-C(2)  1.891(4) 
O(1)-C(9)  1.416(5) 
O(2)-C(10)  1.411(4) 
O(2)-C(13)  1.428(4) 
O(3)-C(11)  1.204(7) 
O(4)-C(24)  1.202(5) 
O(5)-C(24)  1.299(5) 
O(5)-C(25)  1.468(5) 
C(1)-C(2)  1.377(5) 
C(1)-C(6)  1.394(5) 
C(2)-C(3)  1.381(5) 
C(3)-C(4)  1.387(6) 
C(4)-C(5)  1.374(5) 
C(5)-C(6)  1.401(5) 
C(6)-C(7)  1.468(5) 
C(7)-C(8)  1.321(5) 
C(8)-C(9)  1.507(5) 
C(9)-C(10)  1.542(4) 
C(9)-C(24)  1.548(5) 
C(10)-C(11)  1.516(5) 
C(11)-C(12)  1.502(9) 
C(13)-C(14)  1.505(5) 
C(14)-C(23)  1.360(5) 
C(14)-C(15)  1.406(6) 
C(15)-C(16)  1.353(6) 
C(16)-C(17)  1.421(5) 
C(17)-C(18)  1.410(5) 




C(18)-C(19)  1.358(6) 
C(19)-C(20)  1.394(7) 
C(20)-C(21)  1.361(6) 
C(21)-C(22)  1.406(5) 
C(22)-C(23)  1.418(5) 


























































Table 4.   Anisotropic displacement parameters  (Å2x 103) for 4-5n.  The anisotropic 
displacement factor exponent takes the form:  -22[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
________________________________________________________________________  
Br(1) 30(1)  54(1) 62(1)  -7(1) 1(1)  -4(1) 
O(1) 37(2)  38(2) 37(2)  -4(1) 7(1)  4(1) 
O(2) 26(1)  46(2) 32(1)  -5(1) 7(1)  1(1) 
O(3) 49(2)  168(5) 46(2)  -13(2) 29(2)  1(2) 
O(4) 71(2)  77(2) 44(1)  -22(2) 31(1)  -14(2) 
O(5) 55(2)  50(2) 41(2)  -3(1) 29(1)  -7(1) 
C(1) 32(2)  28(2) 28(2)  -2(1) 7(1)  1(1) 
C(2) 29(2)  36(2) 30(2)  1(2) 7(2)  0(2) 
C(3) 39(2)  39(2) 44(2)  1(2) 15(2)  9(2) 
C(4) 46(2)  33(2) 52(2)  -1(2) 19(2)  12(3) 
C(5) 39(2)  37(2) 41(2)  -6(2) 11(2)  -5(2) 
C(6) 29(2)  36(2) 23(2)  4(2) 9(1)  -1(2) 
C(7) 32(2)  33(2) 28(2)  -1(1) 10(2)  3(2) 
C(8) 31(2)  35(2) 26(2)  -1(2) 10(2)  1(2) 
C(9) 27(2)  36(3) 26(2)  1(2) 9(1)  -1(2) 
C(10) 24(2)  49(2) 28(2)  -2(2) 8(1)  1(2) 
C(11) 30(2)  102(4) 27(2)  0(3) 3(2)  -12(3) 
C(12) 77(4)  123(6) 66(3)  55(4) 19(3)  -17(4) 
C(13) 28(2)  67(3) 49(2)  -21(2) 4(2)  0(2) 
C(14) 26(2)  45(2) 35(2)  -11(2) 1(2)  -2(2) 
C(15) 31(2)  56(3) 35(2)  -8(2) 10(2)  -17(2) 
C(16) 39(2)  38(2) 31(2)  -2(2) 6(2)  -12(2) 
C(17) 30(2)  34(2) 23(2)  -4(2) 3(1)  -5(2) 




C(19) 32(2)  71(3) 39(2)  -7(2) 8(2)  12(2) 
C(20) 48(3)  69(3) 38(2)  -7(2) 21(2)  -13(2) 
C(21) 45(2)  42(2) 30(2)  -1(2) 13(1)  -4(2) 
C(22) 32(2)  34(2) 24(2)  -1(1) 6(1)  -5(2) 
C(23) 35(2)  36(2) 29(2)  -2(2) 1(1)  4(2) 
C(24) 30(2)  52(2) 27(2)  -3(2) 8(2)  6(2) 
C(25) 56(3)  73(3) 49(2)  10(2) 33(2)  -3(2) 





Table 5.   Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 10 
3) for 4-5n. 
________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________  
  
H(1) 6402 6627 8562 58 
H(1A) 10076 4945 9405 36 
H(3) 11949 -182 9107 48 
H(4) 10407 -2192 8304 52 
H(5) 8714 -657 8029 47 
H(7) 8179 4965 8690 38 
H(8) 7146 1087 7876 37 
H(10) 5238 1962 6847 40 
H(12A) 6184 7411 5720 134 
H(12B) 5763 7852 6530 134 
H(12C) 4942 7109 5593 134 
H(13A) 3403 2123 6436 60 
H(13B) 3580 3662 5678 60 
H(15) 2844 7734 5553 50 
H(16) 1336 9817 5416 45 
H(18) -482 10140 5627 47 
H(19) -1779 8598 6120 57 
H(20) -1509 5089 6828 60 
H(21) 86 3176 7087 47 
H(23) 1880 2836 6864 43 
H(25A) 4221 1418 9132 66 
H(25B) 5075 -591 9419 66 




H(26B) 3482 -2310 8744 95 





Table 6.  Hydrogen bonds for 4-5n  [Å and °]. 
________________________________________________________________________  
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
________________________________________________________________________  
 O(1)-H(1)...O(4) 0.83 2.17 2.646(4) 116.4 
 O(1)-H(1)...Br(1)#1 0.83 2.89 3.573(3) 141.2 
________________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
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